 |
Bahramali, Golnaz
Expression of a Novel Fusion Recombinant Protein VP8-VP1 in Escherichia coli as a Rota-HAV Vaccine Candidate [Volume 10, Number 1] |
|
Hamidi-Fard, Mojtaba
Expression of a Novel Fusion Recombinant Protein VP8-VP1 in Escherichia coli as a Rota-HAV Vaccine Candidate [Volume 10, Number 1] |
|
Akhavan Sepahi, Abbas
Expression of a Novel Fusion Recombinant Protein VP8-VP1 in Escherichia coli as a Rota-HAV Vaccine Candidate [Volume 10, Number 1] |
|
Aghasadeghi, Mohammadreza
Expression of a Novel Fusion Recombinant Protein VP8-VP1 in Escherichia coli as a Rota-HAV Vaccine Candidate [Volume 10, Number 1] |
|
Yarmohammadi, Hassan
Expression of a Novel Fusion Recombinant Protein VP8-VP1 in Escherichia coli as a Rota-HAV Vaccine Candidate [Volume 10, Number 1] |
|
Najafi, Azar
Immunoinformatics Analyses of a Selection of Important Leishmania major Vaccine Epitopes: an in silico Approach [Volume 10, Number 2] |
|
Majidiani, Hamidreza
Immunoinformatics Analyses of a Selection of Important Leishmania major Vaccine Epitopes: an in silico Approach [Volume 10, Number 2] |
|
Heydarian, Saeed
Immunoinformatics Analyses of a Selection of Important Leishmania major Vaccine Epitopes: an in silico Approach [Volume 10, Number 2] |
|
Hosseini, Seyyed Amir
Immunoinformatics Analyses of a Selection of Important Leishmania major Vaccine Epitopes: an in silico Approach [Volume 10, Number 2] |
|
Zandieh, Mohammad Arad
Immunoinformatics Analyses of a Selection of Important Leishmania major Vaccine Epitopes: an in silico Approach [Volume 10, Number 2] |
|
Kalantarzadeh, Faezeh
Immunoinformatics Analyses of a Selection of Important Leishmania major Vaccine Epitopes: an in silico Approach [Volume 10, Number 2] |
|
Jahani, Negar
Immunoinformatics Analyses of a Selection of Important Leishmania major Vaccine Epitopes: an in silico Approach [Volume 10, Number 2] |
|
Siamian, Davood
Immunoinformatics Analyses of a Selection of Important Leishmania major Vaccine Epitopes: an in silico Approach [Volume 10, Number 2] |
|
Khazaei, Sasan
Immunoinformatics Analyses of a Selection of Important Leishmania major Vaccine Epitopes: an in silico Approach [Volume 10, Number 2] |
|
Alem, Mahsa
Immunoinformatics Analyses of a Selection of Important Leishmania major Vaccine Epitopes: an in silico Approach [Volume 10, Number 2] |
|
Rezaeirad, Arash
Immunoinformatics Analyses of a Selection of Important Leishmania major Vaccine Epitopes: an in silico Approach [Volume 10, Number 2] |
|
Alipourfard, Iraj
Immunoinformatics Analyses of a Selection of Important Leishmania major Vaccine Epitopes: an in silico Approach [Volume 10, Number 2] |
|
Farahzadeh, Golnoush
Immunoinformatics Analyses of a Selection of Important Leishmania major Vaccine Epitopes: an in silico Approach [Volume 10, Number 2] |
|
Rezayatmand, Hamed
Immunoinformatics Analyses of a Selection of Important Leishmania major Vaccine Epitopes: an in silico Approach [Volume 10, Number 2] |
|
Norouzian, Dariush
Endotoxin Removal from Biopharmaceuticals and Vaccines by an Antimicrobial Peptide-Based Affinity Matrix: a Kinetics Study [Volume 10, Number 2] |
|
Ahangari Cohan, Reza
Endotoxin Removal from Biopharmaceuticals and Vaccines by an Antimicrobial Peptide-Based Affinity Matrix: a Kinetics Study [Volume 10, Number 2] |
|
Hadadian, Shahin
Endotoxin Removal from Biopharmaceuticals and Vaccines by an Antimicrobial Peptide-Based Affinity Matrix: a Kinetics Study [Volume 10, Number 2] |
|
Sepahi, Mina
Endotoxin Removal from Biopharmaceuticals and Vaccines by an Antimicrobial Peptide-Based Affinity Matrix: a Kinetics Study [Volume 10, Number 2] |
|
Marandi, Vahid
Mitigation of Scale-Up Risks in Technology Transfer of Vaccines and other Bioproducts [Volume 10, Number 2] |
|
Khosravy, Mohammad Sadeq
Rabies vaccine: progress and prospective [Volume 10, Number 1] |
|
Rahpeyma, Mehdi
Rabies vaccine: progress and prospective [Volume 10, Number 1] |
|
Hashemi, Zahra Sadat
SARS-CoV-2 Lambda and Omicron Variants: Antigenicity Evaluation of Spike Proteins as Potential Targets for Vaccine Development [Volume 10, Number 1] |
|
Khalili, Saeed
SARS-CoV-2 Lambda and Omicron Variants: Antigenicity Evaluation of Spike Proteins as Potential Targets for Vaccine Development [Volume 10, Number 1] |
|
Zakeri, Alireza
SARS-CoV-2 Lambda and Omicron Variants: Antigenicity Evaluation of Spike Proteins as Potential Targets for Vaccine Development [Volume 10, Number 1] |
|
Zarei, Mahboubeh
SARS-CoV-2 Lambda and Omicron Variants: Antigenicity Evaluation of Spike Proteins as Potential Targets for Vaccine Development [Volume 10, Number 1] |
|
Tafreshi, Say-yed Hesameddin
Which One Should Be Prioritized During Pandemics: Patents or Global Health? [Volume 10, Number 1] |
|
Farokhi, Mehdi
In silico Evaluation, Cloning, and Expression of Omp22 as a Promising Vaccine Candidate against Acinetobacter baumannii [Volume 10, Number 1] |
|
Asadi Karam, Mohammd Reza
In silico Evaluation, Cloning, and Expression of Omp22 as a Promising Vaccine Candidate against Acinetobacter baumannii [Volume 10, Number 1] |
|
Shahbazi, Shahla
In silico Evaluation, Cloning, and Expression of Omp22 as a Promising Vaccine Candidate against Acinetobacter baumannii [Volume 10, Number 1] |
|
Habibi, Mehri
In silico Evaluation, Cloning, and Expression of Omp22 as a Promising Vaccine Candidate against Acinetobacter baumannii [Volume 10, Number 1] |
|
Noori Goodarzi, Narjes
In silico Evaluation, Cloning, and Expression of Omp22 as a Promising Vaccine Candidate against Acinetobacter baumannii [Volume 10, Number 1] |
|
Badmasti, Farzad
In silico Evaluation, Cloning, and Expression of Omp22 as a Promising Vaccine Candidate against Acinetobacter baumannii [Volume 10, Number 1] |
|
Sabzi, Samira
In silico Evaluation, Cloning, and Expression of Omp22 as a Promising Vaccine Candidate against Acinetobacter baumannii [Volume 10, Number 1] |
|
Sadat , Seyed Mehdi
Novel Protein Expression and Purification of SARS CoV-2 from Recombinant Escherichia coli System [Volume 10, Number 1] |
|
Aghasadeghi , Mohammad Reza
Novel Protein Expression and Purification of SARS CoV-2 from Recombinant Escherichia coli System [Volume 10, Number 1] |
|
Bahramali , Golnaz
Novel Protein Expression and Purification of SARS CoV-2 from Recombinant Escherichia coli System [Volume 10, Number 1] |
|
Hannan, Mina
Novel Protein Expression and Purification of SARS CoV-2 from Recombinant Escherichia coli System [Volume 10, Number 1] |
|
Mashhadi Abolghasem Shirazi, Maryam
Novel Protein Expression and Purification of SARS CoV-2 from Recombinant Escherichia coli System [Volume 10, Number 1] |
|
Asadi Karam, Mohammad Reza
Evaluation of the Effectiveness of Polyclonal Antibody Developed against a Recombinant Multi-Epitope Protein Composed of Uropathogenic Escherichia coli Antigens [Volume 10, Number 1] |
|
Hosseini Doust, Reza
Evaluation of the Effectiveness of Polyclonal Antibody Developed against a Recombinant Multi-Epitope Protein Composed of Uropathogenic Escherichia coli Antigens [Volume 10, Number 1] |
|
Habibi, Mehri
Evaluation of the Effectiveness of Polyclonal Antibody Developed against a Recombinant Multi-Epitope Protein Composed of Uropathogenic Escherichia coli Antigens [Volume 10, Number 1] |
|
Hedayat, Sheida
Evaluation of the Effectiveness of Polyclonal Antibody Developed against a Recombinant Multi-Epitope Protein Composed of Uropathogenic Escherichia coli Antigens [Volume 10, Number 1] |
|
Salehi, Mitra
Phylogenetic Analysis, Cloning and Expression of Delta Amastin Encoding Gene from Leishmania major as a Vaccine Candidate [Volume 9, Number 1] |
|
Razavi, Mohamad Reza
Phylogenetic Analysis, Cloning and Expression of Delta Amastin Encoding Gene from Leishmania major as a Vaccine Candidate [Volume 9, Number 1] |
|
Yadegari, Zahra
Phylogenetic Analysis, Cloning and Expression of Delta Amastin Encoding Gene from Leishmania major as a Vaccine Candidate [Volume 9, Number 1] |
|
Sheikhpour, Mojgan
A Global Overview of Tuberculosis Vaccine Development [Volume 9, Number 2] |
|
Kariman, Arian
A Global Overview of Tuberculosis Vaccine Development [Volume 9, Number 2] |
|
Rahimi , Erfan
A Global Overview of Tuberculosis Vaccine Development [Volume 9, Number 2] |
|
Hadadian, Shahin
Enhancing the Accuracy of Semi-quantitative Endotoxin Evaluation in Biopharmaceuticals and Vaccines R&D [Volume 9, Number 2] |
|
Sedighi, Samin
Enhancing the Accuracy of Semi-quantitative Endotoxin Evaluation in Biopharmaceuticals and Vaccines R&D [Volume 9, Number 2] |
|
Sepahi, Mina
Enhancing the Accuracy of Semi-quantitative Endotoxin Evaluation in Biopharmaceuticals and Vaccines R&D [Volume 9, Number 2] |
|
Homma, Akira
Vaccine Innovation for Dengue, Chikungunya, Zika and Yellow Fever: Accelerating Global Development Agenda and Partnerships in Post-COVID Era [Volume 9, Number 2] |
|
Marques, Ernesto TA
Vaccine Innovation for Dengue, Chikungunya, Zika and Yellow Fever: Accelerating Global Development Agenda and Partnerships in Post-COVID Era [Volume 9, Number 2] |
|
Schumacher, Suzanne
Vaccine Innovation for Dengue, Chikungunya, Zika and Yellow Fever: Accelerating Global Development Agenda and Partnerships in Post-COVID Era [Volume 9, Number 2] |
|
Oliveira, Alessandra
Vaccine Innovation for Dengue, Chikungunya, Zika and Yellow Fever: Accelerating Global Development Agenda and Partnerships in Post-COVID Era [Volume 9, Number 2] |
|
Antunes, Adelaide
Vaccine Innovation for Dengue, Chikungunya, Zika and Yellow Fever: Accelerating Global Development Agenda and Partnerships in Post-COVID Era [Volume 9, Number 2] |
|
Possas, Cristina
Vaccine Innovation for Dengue, Chikungunya, Zika and Yellow Fever: Accelerating Global Development Agenda and Partnerships in Post-COVID Era [Volume 9, Number 2] |
|
Ganji, Ali
Efficacy of Two Vaccine Platforms against SARS-CoV-2 [Volume 9, Number 2] |
|
Navabi, Parnian
Efficacy of Two Vaccine Platforms against SARS-CoV-2 [Volume 9, Number 2] |
|
Keshavarzian, Nafiseh
Efficacy of Two Vaccine Platforms against SARS-CoV-2 [Volume 9, Number 2] |
|
Mosayebi, Ghasem
Efficacy of Two Vaccine Platforms against SARS-CoV-2 [Volume 9, Number 2] |
|
khaki, Mohsen
Efficacy of Two Vaccine Platforms against SARS-CoV-2 [Volume 9, Number 2] |
|
ghazavi, Ali
Efficacy of Two Vaccine Platforms against SARS-CoV-2 [Volume 9, Number 2] |
|
Marandi, Vahid
Policy Coherence for Vaccine Production to Reduce Health Inequalities [Volume 9, Number 2] |
|
Oyedoyin, Ifeoluwa
Attitude, Perception and Concern towards Children’s Vaccination amidst COVID-19 Pandemic among Selected Workers in a Nigerian Population [Volume 9, Number 1] |
|
Abdulsalam, Abimbola
Attitude, Perception and Concern towards Children’s Vaccination amidst COVID-19 Pandemic among Selected Workers in a Nigerian Population [Volume 9, Number 1] |
|
Opeyemi, Oluwatosin
Attitude, Perception and Concern towards Children’s Vaccination amidst COVID-19 Pandemic among Selected Workers in a Nigerian Population [Volume 9, Number 1] |
|
Okafor, Nkemjika
Attitude, Perception and Concern towards Children’s Vaccination amidst COVID-19 Pandemic among Selected Workers in a Nigerian Population [Volume 9, Number 1] |
|
Idoko, Michael
Attitude, Perception and Concern towards Children’s Vaccination amidst COVID-19 Pandemic among Selected Workers in a Nigerian Population [Volume 9, Number 1] |
|
Nmesomachi, Sylvia
Attitude, Perception and Concern towards Children’s Vaccination amidst COVID-19 Pandemic among Selected Workers in a Nigerian Population [Volume 9, Number 1] |
|
Itodo, Eleojo
Attitude, Perception and Concern towards Children’s Vaccination amidst COVID-19 Pandemic among Selected Workers in a Nigerian Population [Volume 9, Number 1] |
|
Yelpoji, Umanka
Attitude, Perception and Concern towards Children’s Vaccination amidst COVID-19 Pandemic among Selected Workers in a Nigerian Population [Volume 9, Number 1] |
|
Edafetanure-Ibeh, Marcel
Attitude, Perception and Concern towards Children’s Vaccination amidst COVID-19 Pandemic among Selected Workers in a Nigerian Population [Volume 9, Number 1] |
|
Dada, Olugbamila
Attitude, Perception and Concern towards Children’s Vaccination amidst COVID-19 Pandemic among Selected Workers in a Nigerian Population [Volume 9, Number 1] |
|
Oyekale, Oyekunle
Attitude, Perception and Concern towards Children’s Vaccination amidst COVID-19 Pandemic among Selected Workers in a Nigerian Population [Volume 9, Number 1] |
|
Ezigbo, Doris
Attitude, Perception and Concern towards Children’s Vaccination amidst COVID-19 Pandemic among Selected Workers in a Nigerian Population [Volume 9, Number 1] |
|
Adejumo, Ngozi
Attitude, Perception and Concern towards Children’s Vaccination amidst COVID-19 Pandemic among Selected Workers in a Nigerian Population [Volume 9, Number 1] |
|
Akele, Yomi
Attitude, Perception and Concern towards Children’s Vaccination amidst COVID-19 Pandemic among Selected Workers in a Nigerian Population [Volume 9, Number 1] |
|
Durosinmi, Abiodun
Attitude, Perception and Concern towards Children’s Vaccination amidst COVID-19 Pandemic among Selected Workers in a Nigerian Population [Volume 9, Number 1] |
|
Samson, Enitan
Attitude, Perception and Concern towards Children’s Vaccination amidst COVID-19 Pandemic among Selected Workers in a Nigerian Population [Volume 9, Number 1] |
|
Oyekale, Adesola
Acceptance of COVID-19 Vaccination at Different Hypothetical Efficacy and Safety Levels in Nigeria: A Cross-Sectional Web-based Survey [Volume 9, Number 1] |
|
Okafor, Edwin
Acceptance of COVID-19 Vaccination at Different Hypothetical Efficacy and Safety Levels in Nigeria: A Cross-Sectional Web-based Survey [Volume 9, Number 1] |
|
Nmesomachi, Ogbuji
Acceptance of COVID-19 Vaccination at Different Hypothetical Efficacy and Safety Levels in Nigeria: A Cross-Sectional Web-based Survey [Volume 9, Number 1] |
|
Opeyemi, Ogunwola
Acceptance of COVID-19 Vaccination at Different Hypothetical Efficacy and Safety Levels in Nigeria: A Cross-Sectional Web-based Survey [Volume 9, Number 1] |
|
Idoko, Abah
Acceptance of COVID-19 Vaccination at Different Hypothetical Efficacy and Safety Levels in Nigeria: A Cross-Sectional Web-based Survey [Volume 9, Number 1] |
|
Yelpoji, Polit
Acceptance of COVID-19 Vaccination at Different Hypothetical Efficacy and Safety Levels in Nigeria: A Cross-Sectional Web-based Survey [Volume 9, Number 1] |
|
Oyedoyin, Oyekan
Acceptance of COVID-19 Vaccination at Different Hypothetical Efficacy and Safety Levels in Nigeria: A Cross-Sectional Web-based Survey [Volume 9, Number 1] |
|
Edafetanure-Ibeh, Okeoghene
Acceptance of COVID-19 Vaccination at Different Hypothetical Efficacy and Safety Levels in Nigeria: A Cross-Sectional Web-based Survey [Volume 9, Number 1] |
|
Dada, Michael
Acceptance of COVID-19 Vaccination at Different Hypothetical Efficacy and Safety Levels in Nigeria: A Cross-Sectional Web-based Survey [Volume 9, Number 1] |
|
Abdulsalam, Adedeji
Acceptance of COVID-19 Vaccination at Different Hypothetical Efficacy and Safety Levels in Nigeria: A Cross-Sectional Web-based Survey [Volume 9, Number 1] |
|
Itodo, Grace
Acceptance of COVID-19 Vaccination at Different Hypothetical Efficacy and Safety Levels in Nigeria: A Cross-Sectional Web-based Survey [Volume 9, Number 1] |
|
Durosinmi, Abiodun
Acceptance of COVID-19 Vaccination at Different Hypothetical Efficacy and Safety Levels in Nigeria: A Cross-Sectional Web-based Survey [Volume 9, Number 1] |
|
Ezigbo, Eyiuche
Acceptance of COVID-19 Vaccination at Different Hypothetical Efficacy and Safety Levels in Nigeria: A Cross-Sectional Web-based Survey [Volume 9, Number 1] |
|
Adejumo, Esther
Acceptance of COVID-19 Vaccination at Different Hypothetical Efficacy and Safety Levels in Nigeria: A Cross-Sectional Web-based Survey [Volume 9, Number 1] |
|
Enitan, Seyi
Acceptance of COVID-19 Vaccination at Different Hypothetical Efficacy and Safety Levels in Nigeria: A Cross-Sectional Web-based Survey [Volume 9, Number 1] |
|
Akele, Richard
Acceptance of COVID-19 Vaccination at Different Hypothetical Efficacy and Safety Levels in Nigeria: A Cross-Sectional Web-based Survey [Volume 9, Number 1] |
|
Ahangarzadeh, Shahrzad
In-Silico Design of a Novel Multi-Epitope Fimbriae Vaccine against Non-typhoidal Salmonella [Volume 10, Number 1] |
|
Beikzadeh, Babak
In-Silico Design of a Novel Multi-Epitope Fimbriae Vaccine against Non-typhoidal Salmonella [Volume 10, Number 1] |
|
Bolhassani, Azam
The Effects of Heat Shock Proteins on the Expression of HIV-1 Nef Antigen in Mammalian Cells [Volume 7, Number 1] |
|
Naseroleslami, Maryam
The Effects of Heat Shock Proteins on the Expression of HIV-1 Nef Antigen in Mammalian Cells [Volume 7, Number 1] |
|
Rouhollah, Fatemeh
The Effects of Heat Shock Proteins on the Expression of HIV-1 Nef Antigen in Mammalian Cells [Volume 7, Number 1] |
|
Milani, Alireza
The Effects of Heat Shock Proteins on the Expression of HIV-1 Nef Antigen in Mammalian Cells [Volume 7, Number 1] |
|
Sarmadian, Roham
Comparison of the Effects of Different COVID-19 Vaccine Platforms on the Hospitalization Rate [Volume 9, Number 2] |
|
Baradaran Sirjani, Ehsan
Comparison of the Effects of Different COVID-19 Vaccine Platforms on the Hospitalization Rate [Volume 9, Number 2] |
|
Khazaei Fard, Fatemeh
Comparison of the Effects of Different COVID-19 Vaccine Platforms on the Hospitalization Rate [Volume 9, Number 2] |
|
Hajebi Khaniki, Saeedeh
Comparison of the Effects of Different COVID-19 Vaccine Platforms on the Hospitalization Rate [Volume 9, Number 2] |
|
Gilani, Abolfazl
Comparison of the Effects of Different COVID-19 Vaccine Platforms on the Hospitalization Rate [Volume 9, Number 2] |
|
Mousavi, Fatemeh Sadat
Yeast-Produced S1 Recombinant Protein of SARS-CoV-2 [Volume 9, Number 2] |
|
Najafi, Hamideh
Yeast-Produced S1 Recombinant Protein of SARS-CoV-2 [Volume 9, Number 2] |
|
Mohammadi, Ashraf
Yeast-Produced S1 Recombinant Protein of SARS-CoV-2 [Volume 9, Number 2] |
|
Akrami, Meisam
Yeast-Produced S1 Recombinant Protein of SARS-CoV-2 [Volume 9, Number 2] |
|
Abedi Kiasari, Bahmann
Yeast-Produced S1 Recombinant Protein of SARS-CoV-2 [Volume 9, Number 2] |
|
Aghaeipour, Khosrow
Yeast-Produced S1 Recombinant Protein of SARS-CoV-2 [Volume 9, Number 2] |
|
Majidi, Sanaz
Yeast-Produced S1 Recombinant Protein of SARS-CoV-2 [Volume 9, Number 2] |
|
Siadat, Seyed davar
Isolation of Extracellular Vesicles of Akkermansia muciniphila as a Potential Therapeutic Platform [Volume 9, Number 2] |
|
Rahimi, Pooneh
Isolation of Extracellular Vesicles of Akkermansia muciniphila as a Potential Therapeutic Platform [Volume 9, Number 2] |
|
Sotoodehnejadnematalali, Fattah
Isolation of Extracellular Vesicles of Akkermansia muciniphila as a Potential Therapeutic Platform [Volume 9, Number 2] |
|
Noori, Pegah
Isolation of Extracellular Vesicles of Akkermansia muciniphila as a Potential Therapeutic Platform [Volume 9, Number 2] |
|
Raina, Vimarsh
Prevalence and Genetic Polymorphism of HLA-B*15 in the North Indian Population: Insights into SJS/TEN Prevention, Vaccines and Clinical Trials [Volume 9, Number 1] |
|
Bhardwaj, Amit Kr.
Prevalence and Genetic Polymorphism of HLA-B*15 in the North Indian Population: Insights into SJS/TEN Prevention, Vaccines and Clinical Trials [Volume 9, Number 1] |
|
Sharma, Ritu
Prevalence and Genetic Polymorphism of HLA-B*15 in the North Indian Population: Insights into SJS/TEN Prevention, Vaccines and Clinical Trials [Volume 9, Number 1] |
|
Chandra, Dinesh
Prevalence and Genetic Polymorphism of HLA-B*15 in the North Indian Population: Insights into SJS/TEN Prevention, Vaccines and Clinical Trials [Volume 9, Number 1] |
|
Raina, Anoushka
Prevalence and Genetic Polymorphism of HLA-B*15 in the North Indian Population: Insights into SJS/TEN Prevention, Vaccines and Clinical Trials [Volume 9, Number 1] |
|
Mishra, Vikash Chandra
Prevalence and Genetic Polymorphism of HLA-B*15 in the North Indian Population: Insights into SJS/TEN Prevention, Vaccines and Clinical Trials [Volume 9, Number 1] |
|
Zangeneh, Mehrangiz
Basic characteristics of patients with COVID-19 after SARS‐CoV‐2 vaccine: One cross-sectional study in Iran [Volume 9, Number 1] |
|
Tarjoman, Termeh
Basic characteristics of patients with COVID-19 after SARS‐CoV‐2 vaccine: One cross-sectional study in Iran [Volume 9, Number 1] |
|
Khosravani-Nezhad, Yasamin
Basic characteristics of patients with COVID-19 after SARS‐CoV‐2 vaccine: One cross-sectional study in Iran [Volume 9, Number 1] |
|
Chouhdari, Arezoo
Basic characteristics of patients with COVID-19 after SARS‐CoV‐2 vaccine: One cross-sectional study in Iran [Volume 9, Number 1] |
|
Mousavi, Seyed fazlollah
In-silico Analysis of Pneumococcal Heat-Shock Protein (DnaJ) to Predict Novel Multi-Epitope Vaccine Candidates [Volume 9, Number 1] |
|
Sotoodehnejadnematalahi, Fattah
In-silico Analysis of Pneumococcal Heat-Shock Protein (DnaJ) to Predict Novel Multi-Epitope Vaccine Candidates [Volume 9, Number 1] |
|
Ahangari Cohan, Reza
In-silico Analysis of Pneumococcal Heat-Shock Protein (DnaJ) to Predict Novel Multi-Epitope Vaccine Candidates [Volume 9, Number 1] |
|
Afshari, Elnaz
In-silico Analysis of Pneumococcal Heat-Shock Protein (DnaJ) to Predict Novel Multi-Epitope Vaccine Candidates [Volume 9, Number 1] |
|
Joseph, Bobby
The Healthcare Workers’ Vaccination – current Policy and Recommendations [Volume 9, Number 1] |
|
Joseph, Merlyn
The Healthcare Workers’ Vaccination – current Policy and Recommendations [Volume 9, Number 1] |
|
Chubin, Hamzeh
Establishment a Carcinoembryonic Antigen Stable Cell Line for Cancer Immunotherapy Study [Volume 9, Number 1] |
|
Pouriayevali, Mohammad hassan
Establishment a Carcinoembryonic Antigen Stable Cell Line for Cancer Immunotherapy Study [Volume 9, Number 1] |
|
Bamdad, Taravat
Establishment a Carcinoembryonic Antigen Stable Cell Line for Cancer Immunotherapy Study [Volume 9, Number 1] |
|
asiyabi, sanaz
Establishment a Carcinoembryonic Antigen Stable Cell Line for Cancer Immunotherapy Study [Volume 9, Number 1] |
|
Keser, Gokhan
An Update on Pathogenesis, Diagnosis and Treatment of COVID-19-Related Cytokine Storm [Volume 8, Number 2] |
|
ATAGUNDUZ, Pamir
An Update on Pathogenesis, Diagnosis and Treatment of COVID-19-Related Cytokine Storm [Volume 8, Number 2] |
|
soy, Mehmet
An Update on Pathogenesis, Diagnosis and Treatment of COVID-19-Related Cytokine Storm [Volume 8, Number 2] |
|
Irani, Shiva
Evaluation of the Effect of HSV-tk/GCV Adenoviral Vector Vaccine Candidate in Inhibiting the Growth of Myeloma Tumors by Inducing Autophagy in BALB/c Mice [Volume 8, Number 2] |
|
Abdoli, Asghar
Evaluation of the Effect of HSV-tk/GCV Adenoviral Vector Vaccine Candidate in Inhibiting the Growth of Myeloma Tumors by Inducing Autophagy in BALB/c Mice [Volume 8, Number 2] |
|
Sadat, Seyed Mehdi
Evaluation of the Effect of HSV-tk/GCV Adenoviral Vector Vaccine Candidate in Inhibiting the Growth of Myeloma Tumors by Inducing Autophagy in BALB/c Mice [Volume 8, Number 2] |
|
Baesi, Kazem
Evaluation of the Effect of HSV-tk/GCV Adenoviral Vector Vaccine Candidate in Inhibiting the Growth of Myeloma Tumors by Inducing Autophagy in BALB/c Mice [Volume 8, Number 2] |
|
poorghobadi, shima
Evaluation of the Effect of HSV-tk/GCV Adenoviral Vector Vaccine Candidate in Inhibiting the Growth of Myeloma Tumors by Inducing Autophagy in BALB/c Mice [Volume 8, Number 2] |
|
Siadat, Seyed Davar
The Optimization of Faecalibacterium prausnitzii Extracellular Vesicle Concentrations on PPARγ and FIAF Expression in the Caco-2 Cell Culture Model [Volume 8, Number 2] |
|
Vaziri, Farzam
The Optimization of Faecalibacterium prausnitzii Extracellular Vesicle Concentrations on PPARγ and FIAF Expression in the Caco-2 Cell Culture Model [Volume 8, Number 2] |
|
Mousavi, Seyed Fazlollah
The Optimization of Faecalibacterium prausnitzii Extracellular Vesicle Concentrations on PPARγ and FIAF Expression in the Caco-2 Cell Culture Model [Volume 8, Number 2] |
|
Akhavan Sepahi, Abbas
The Optimization of Faecalibacterium prausnitzii Extracellular Vesicle Concentrations on PPARγ and FIAF Expression in the Caco-2 Cell Culture Model [Volume 8, Number 2] |
|
Moosavi, Seyedeh Marzieh
The Optimization of Faecalibacterium prausnitzii Extracellular Vesicle Concentrations on PPARγ and FIAF Expression in the Caco-2 Cell Culture Model [Volume 8, Number 2] |
|
Sadat, Seyed Mehdi
Immunoinformatics Approach for Designing an HPV Epitope-Based Vaccine Candidate Harboring Built-in Adjuvants [Volume 8, Number 2] |
|
Roohvand, Farzin
Immunoinformatics Approach for Designing an HPV Epitope-Based Vaccine Candidate Harboring Built-in Adjuvants [Volume 8, Number 2] |
|
Haghighat, Setareh
Immunoinformatics Approach for Designing an HPV Epitope-Based Vaccine Candidate Harboring Built-in Adjuvants [Volume 8, Number 2] |
|
Arashkia, Arash
Immunoinformatics Approach for Designing an HPV Epitope-Based Vaccine Candidate Harboring Built-in Adjuvants [Volume 8, Number 2] |
|
Mashhadi Abolghasem Shirazi, Maryam
Immunoinformatics Approach for Designing an HPV Epitope-Based Vaccine Candidate Harboring Built-in Adjuvants [Volume 8, Number 2] |
|
Ravichandran, Swetha
Commentary on Corneal Graft Rejection after COVID-19 Vaccination: Our Experience and Concerns [Volume 8, Number 2] |
|
Natarajan, Radhika
Commentary on Corneal Graft Rejection after COVID-19 Vaccination: Our Experience and Concerns [Volume 8, Number 2] |
|
Bagheri, Masoumeh
Roles and Functions of Toll-Like Receptors in Coronavirus Infections: Forthcoming Vaccine and Therapeutic Strategies for Confronting COVID-19 [Volume 8, Number 2] |
|
Zahmatkesh, Azadeh
Roles and Functions of Toll-Like Receptors in Coronavirus Infections: Forthcoming Vaccine and Therapeutic Strategies for Confronting COVID-19 [Volume 8, Number 2] |
|
Tebianain, Majid
The predominance of Newcastle disease virus genotype VII: genome diversity or poor cross-immunity of non-matched vaccines [Volume 8, Number 2] |
|
Ebrahimi, Mohammad Majid
The predominance of Newcastle disease virus genotype VII: genome diversity or poor cross-immunity of non-matched vaccines [Volume 8, Number 2] |
|
Shahsavandi, Shahla
The predominance of Newcastle disease virus genotype VII: genome diversity or poor cross-immunity of non-matched vaccines [Volume 8, Number 2] |
|
Teo, Shyh Poh
Lessons Learned from Global Administration of Sinopharm (BBIBP-CorV) Vaccine and Its Efficacy against COVID-19 in Older People [Volume 8, Number 2] |
|
Doroud, Delaram
Comparative Study of AEFI of Hepatitis B Vaccine between Iran Ministry of Health CDC and VAERS Data during 2015 to 2017 [Volume 8, Number 1] |
|
Aghasadeghi, Mohammadreza
Comparative Study of AEFI of Hepatitis B Vaccine between Iran Ministry of Health CDC and VAERS Data during 2015 to 2017 [Volume 8, Number 1] |
|
Shamsian, Alireza
Comparative Study of AEFI of Hepatitis B Vaccine between Iran Ministry of Health CDC and VAERS Data during 2015 to 2017 [Volume 8, Number 1] |
|
Hozouri, Hamidreza
Comparative Study of AEFI of Hepatitis B Vaccine between Iran Ministry of Health CDC and VAERS Data during 2015 to 2017 [Volume 8, Number 1] |
|
Leonova, Galina
Evaluation of the effectiveness of infectious diseases immunoprophylaxis (review of our own research on the model of tick-borne encephalitis) [Volume 8, Number 1] |
|
Noormohammadi, Zahra
Construction and Rescue of a Rabies Virus with Duplicated Glycoprotein Gene [Volume 8, Number 1] |
|
Azizi, Mohammad
Construction and Rescue of a Rabies Virus with Duplicated Glycoprotein Gene [Volume 8, Number 1] |
|
Gholami, Alireza
Construction and Rescue of a Rabies Virus with Duplicated Glycoprotein Gene [Volume 8, Number 1] |
|
Alamdary, Ashkan
Construction and Rescue of a Rabies Virus with Duplicated Glycoprotein Gene [Volume 8, Number 1] |
|
Hair-Bejo, Mohd
Comparative Sequence Analysis, Pathogenicity and Immunogenicity of Attenuated Fowl Adenovirus Isolates as Experimental Vaccines against Inclusion Body Hepatitis of Commercial Broiler Chickens [Volume 8, Number 1] |
|
MOHAMED SOHAIMI, NORFITRIAH
Comparative Sequence Analysis, Pathogenicity and Immunogenicity of Attenuated Fowl Adenovirus Isolates as Experimental Vaccines against Inclusion Body Hepatitis of Commercial Broiler Chickens [Volume 8, Number 1] |
|
Woma, Timothy
Assessment of Peste Des Petits Ruminants Antibodies in Vaccinated Yankasa Pregnant Ewes from Nigeria and the Duration of Maternal Immunity in Their Lambs [Volume 8, Number 1] |
|
Markus, Talatu
Assessment of Peste Des Petits Ruminants Antibodies in Vaccinated Yankasa Pregnant Ewes from Nigeria and the Duration of Maternal Immunity in Their Lambs [Volume 8, Number 1] |
|
Adamu, Jibril
Assessment of Peste Des Petits Ruminants Antibodies in Vaccinated Yankasa Pregnant Ewes from Nigeria and the Duration of Maternal Immunity in Their Lambs [Volume 8, Number 1] |
|
Kazeem, Haruna
Assessment of Peste Des Petits Ruminants Antibodies in Vaccinated Yankasa Pregnant Ewes from Nigeria and the Duration of Maternal Immunity in Their Lambs [Volume 8, Number 1] |
|
olaolu, Olushola
Assessment of Peste Des Petits Ruminants Antibodies in Vaccinated Yankasa Pregnant Ewes from Nigeria and the Duration of Maternal Immunity in Their Lambs [Volume 8, Number 1] |
|
Tullao, Joseph
Analysis and Control of an SEIQR Epidemic Model with Application to Ebola Disease Vaccination [Volume 8, Number 1] |
|
Macansantos, Priscilla
Analysis and Control of an SEIQR Epidemic Model with Application to Ebola Disease Vaccination [Volume 8, Number 1] |
|
Teo, Shyh Poh
Cutaneous Reactions after COVID-19 vaccines [Volume 8, Number 1] |
|
Poh, Alicia Wan Yan
Cutaneous Reactions after COVID-19 vaccines [Volume 8, Number 1] |
|
habibi, maziar
Recombinant vaccines against Newcastle Disease: current trends and research agenda [Volume 8, Number 1] |
|
Shahriari, Amir GHaffar
Recombinant vaccines against Newcastle Disease: current trends and research agenda [Volume 8, Number 1] |
|
Zaheri, Hamidreza
Pulmonary Thromboembolism Followed by Deep Vein Thrombosis In A Young Man With G6PD Deficiency After ChAd0x1 nCoV-19 Vaccine Administration [Volume 8, Number 1] |
|
Saeidi, Amirhossein
Pulmonary Thromboembolism Followed by Deep Vein Thrombosis In A Young Man With G6PD Deficiency After ChAd0x1 nCoV-19 Vaccine Administration [Volume 8, Number 1] |
|
Banitorfi, Mohammadhossein
Pulmonary Thromboembolism Followed by Deep Vein Thrombosis In A Young Man With G6PD Deficiency After ChAd0x1 nCoV-19 Vaccine Administration [Volume 8, Number 1] |
|
Rouhani, Zahra Sadat
Pulmonary Thromboembolism Followed by Deep Vein Thrombosis In A Young Man With G6PD Deficiency After ChAd0x1 nCoV-19 Vaccine Administration [Volume 8, Number 1] |
|
Abedini, Atefeh
Pulmonary Thromboembolism Followed by Deep Vein Thrombosis In A Young Man With G6PD Deficiency After ChAd0x1 nCoV-19 Vaccine Administration [Volume 8, Number 1] |
|
kiani, Arda
Pulmonary Thromboembolism Followed by Deep Vein Thrombosis In A Young Man With G6PD Deficiency After ChAd0x1 nCoV-19 Vaccine Administration [Volume 8, Number 1] |
|
Tarverdizade, Yousof
Design and Recombinant Expression of a multiepitope Vaccine Candidate Against Pathogenic Species of Shigella [Volume 8, Number 1] |
|
Akbari, Mohammad Reza
Design and Recombinant Expression of a multiepitope Vaccine Candidate Against Pathogenic Species of Shigella [Volume 8, Number 1] |
|
Sadeghi, Davoud
Design and Recombinant Expression of a multiepitope Vaccine Candidate Against Pathogenic Species of Shigella [Volume 8, Number 1] |
|
Nazarian, Shahram
Design and Recombinant Expression of a multiepitope Vaccine Candidate Against Pathogenic Species of Shigella [Volume 8, Number 1] |
|
Hajizade, Abbas
Design and Recombinant Expression of a multiepitope Vaccine Candidate Against Pathogenic Species of Shigella [Volume 8, Number 1] |
|
Namvar, Amir
Design and Recombinant Expression of a multiepitope Vaccine Candidate Against Pathogenic Species of Shigella [Volume 8, Number 1] |
|
Mesgarian, Masoomeh
Two Months Follow-Up of 139 Unvaccinated COVID-19 Patients Based on Clinical and Imaging Data [Volume 8, Number 1] |
|
Siadat, Seyed-Davar
Two Months Follow-Up of 139 Unvaccinated COVID-19 Patients Based on Clinical and Imaging Data [Volume 8, Number 1] |
|
Massumi-Naini, Hamid-Reza
Two Months Follow-Up of 139 Unvaccinated COVID-19 Patients Based on Clinical and Imaging Data [Volume 8, Number 1] |
|
Farhoodi, Behnam
Two Months Follow-Up of 139 Unvaccinated COVID-19 Patients Based on Clinical and Imaging Data [Volume 8, Number 1] |
|
Alijani, Mohsen
Two Months Follow-Up of 139 Unvaccinated COVID-19 Patients Based on Clinical and Imaging Data [Volume 8, Number 1] |
|
Khosravani-Nezhad, Yasamin
Two Months Follow-Up of 139 Unvaccinated COVID-19 Patients Based on Clinical and Imaging Data [Volume 8, Number 1] |
|
Zangeneh, Mehrangiz
Two Months Follow-Up of 139 Unvaccinated COVID-19 Patients Based on Clinical and Imaging Data [Volume 8, Number 1] |
|
Badmasti, Farzad
Sequence Diversity of FliC Protein from Enterobacteriaceae Family to Introducing a Promising Epitope-Delivery Platform [Volume 7, Number 2] |
|
Fereshteh, Sepideh
Sequence Diversity of FliC Protein from Enterobacteriaceae Family to Introducing a Promising Epitope-Delivery Platform [Volume 7, Number 2] |
|
Gonzalez-Bosquet, Eduardo
Risk Factors for Persistent Human Papillomavirus (HPV) Infection after Conization: A Retrospective Case-Control Study Showed No Significant Association with HPV Vaccination [Volume 7, Number 2] |
|
Garcia Blanco, Miguel
Risk Factors for Persistent Human Papillomavirus (HPV) Infection after Conization: A Retrospective Case-Control Study Showed No Significant Association with HPV Vaccination [Volume 7, Number 2] |
|
Peralta, Leia
Risk Factors for Persistent Human Papillomavirus (HPV) Infection after Conization: A Retrospective Case-Control Study Showed No Significant Association with HPV Vaccination [Volume 7, Number 2] |
|
Sreerama, Krupanidhi
In silico design of multiepitope vaccine candidate against SARS CoV and CoV2 [Volume 7, Number 2] |
|
Martinez, Jorge
Review of Sensitization to prevalent allergens in Iran and their geographical distribution [Volume 7, Number 2] |
|
Dehghani, Mehdi
Review of Sensitization to prevalent allergens in Iran and their geographical distribution [Volume 7, Number 2] |
|
Abtahi, Mohammad
Review of Sensitization to prevalent allergens in Iran and their geographical distribution [Volume 7, Number 2] |
|
Postigo, Idoia
Review of Sensitization to prevalent allergens in Iran and their geographical distribution [Volume 7, Number 2] |
|
Teifoori, Fardis
Review of Sensitization to prevalent allergens in Iran and their geographical distribution [Volume 7, Number 2] |
|
rashidian, Ehsan
Assembling the Most Antigenic Peptides of COVID-19 Immunogenic Proteins Along with a Molecular Adjuvant to Develop a Novel Polyepitope Vaccine: a Bioinformatics Investigation [Volume 8, Number 1] |
|
jaydari, Amin
Assembling the Most Antigenic Peptides of COVID-19 Immunogenic Proteins Along with a Molecular Adjuvant to Develop a Novel Polyepitope Vaccine: a Bioinformatics Investigation [Volume 8, Number 1] |
|
Forouharmehr, Ali
Assembling the Most Antigenic Peptides of COVID-19 Immunogenic Proteins Along with a Molecular Adjuvant to Develop a Novel Polyepitope Vaccine: a Bioinformatics Investigation [Volume 8, Number 1] |
|
nazifi, narges
Assembling the Most Antigenic Peptides of COVID-19 Immunogenic Proteins Along with a Molecular Adjuvant to Develop a Novel Polyepitope Vaccine: a Bioinformatics Investigation [Volume 8, Number 1] |
|
Shams, Nemat
Assembling the Most Antigenic Peptides of COVID-19 Immunogenic Proteins Along with a Molecular Adjuvant to Develop a Novel Polyepitope Vaccine: a Bioinformatics Investigation [Volume 8, Number 1] |
|
Najafi, Hamideh
Production of Polyomavirus and Herpesvirus Recombinant Glycoproteins with Immunoreactivity Using a Rapid and Novel Expression System in Insect Cells for Applications in Vaccines and Serological Assays [Volume 8, Number 1] |
|
Abedi Kiasari, Bahman
Production of Polyomavirus and Herpesvirus Recombinant Glycoproteins with Immunoreactivity Using a Rapid and Novel Expression System in Insect Cells for Applications in Vaccines and Serological Assays [Volume 8, Number 1] |
|
Teo, Shyh Poh
Quantitative Approaches for Causality Assessment of Adverse Events Following Immunisation for COVID-19 Vaccines [Volume 8, Number 1] |
|
Liu, Ge
Potent Therapeutic Efficacy of a Novel HPV16E7-HBcAg-Hsp65 Fusion Protein Vaccine [Volume 8, Number 1] |
|
Fan, Jiang
Potent Therapeutic Efficacy of a Novel HPV16E7-HBcAg-Hsp65 Fusion Protein Vaccine [Volume 8, Number 1] |
|
Zhou, Lingyun
Potent Therapeutic Efficacy of a Novel HPV16E7-HBcAg-Hsp65 Fusion Protein Vaccine [Volume 8, Number 1] |
|
Zhang, Menghua
Potent Therapeutic Efficacy of a Novel HPV16E7-HBcAg-Hsp65 Fusion Protein Vaccine [Volume 8, Number 1] |
|
Jiang, Yuanxiang
Potent Therapeutic Efficacy of a Novel HPV16E7-HBcAg-Hsp65 Fusion Protein Vaccine [Volume 8, Number 1] |
|
Wei, Jian
Potent Therapeutic Efficacy of a Novel HPV16E7-HBcAg-Hsp65 Fusion Protein Vaccine [Volume 8, Number 1] |
|
Xu, Dan
Potent Therapeutic Efficacy of a Novel HPV16E7-HBcAg-Hsp65 Fusion Protein Vaccine [Volume 8, Number 1] |
|
Liu, Haitao
Potent Therapeutic Efficacy of a Novel HPV16E7-HBcAg-Hsp65 Fusion Protein Vaccine [Volume 8, Number 1] |
|
Diao, Meijun
Potent Therapeutic Efficacy of a Novel HPV16E7-HBcAg-Hsp65 Fusion Protein Vaccine [Volume 8, Number 1] |
|
Ma, Xinxing
Potent Therapeutic Efficacy of a Novel HPV16E7-HBcAg-Hsp65 Fusion Protein Vaccine [Volume 8, Number 1] |
|
Wang, Xiaoliang
Potent Therapeutic Efficacy of a Novel HPV16E7-HBcAg-Hsp65 Fusion Protein Vaccine [Volume 8, Number 1] |
|
Zhou, Chenliang
Potent Therapeutic Efficacy of a Novel HPV16E7-HBcAg-Hsp65 Fusion Protein Vaccine [Volume 8, Number 1] |
|
Zhang, Chao
Potent Therapeutic Efficacy of a Novel HPV16E7-HBcAg-Hsp65 Fusion Protein Vaccine [Volume 8, Number 1] |
|
Badmasti, Farzad
In Silico Evaluation of a Mutant Toxic Shock Syndrome Toxin-1 (TSST-1) of Staphylococcus aureus as a Putative Vaccine Candidate [Volume 7, Number 2] |
|
Nazari, Mohsen
In Silico Evaluation of a Mutant Toxic Shock Syndrome Toxin-1 (TSST-1) of Staphylococcus aureus as a Putative Vaccine Candidate [Volume 7, Number 2] |
|
García-Romero, María Teresa
The Skin Immune System and Intradermal Delivery of Vaccines: A Review [Volume 7, Number 2] |
|
Carmona-Cruz, Silvia Angélica
The Skin Immune System and Intradermal Delivery of Vaccines: A Review [Volume 7, Number 2] |
|
Boutrid, Hala
Back to the Basics: The Good Old BCG for COVID-19? [Volume 8, Number 1] |
|
Rahmoune, Hakim
Back to the Basics: The Good Old BCG for COVID-19? [Volume 8, Number 1] |
|
Boutrid, Nada
Back to the Basics: The Good Old BCG for COVID-19? [Volume 8, Number 1] |
|
Pérez, Oliver
Feeding Eggs from Hens Immunized with Specific KLH-Conjugated HIV Peptide Candidate Vaccines to Chicks Induces Specific Anti-HIV gp120 and gp41 Antibodies that Neutralize the Original HIV Antigens [Volume 7, Number 2] |
|
Smikle, Fisher
Feeding Eggs from Hens Immunized with Specific KLH-Conjugated HIV Peptide Candidate Vaccines to Chicks Induces Specific Anti-HIV gp120 and gp41 Antibodies that Neutralize the Original HIV Antigens [Volume 7, Number 2] |
|
Cosme, Ferrer
Feeding Eggs from Hens Immunized with Specific KLH-Conjugated HIV Peptide Candidate Vaccines to Chicks Induces Specific Anti-HIV gp120 and gp41 Antibodies that Neutralize the Original HIV Antigens [Volume 7, Number 2] |
|
Vaillant, Justiz
Feeding Eggs from Hens Immunized with Specific KLH-Conjugated HIV Peptide Candidate Vaccines to Chicks Induces Specific Anti-HIV gp120 and gp41 Antibodies that Neutralize the Original HIV Antigens [Volume 7, Number 2] |
|
Maestroni, Georges
The Well-Recognized Ability of Melatonin to Potentiate an Equilibrated Immune Response Calls for an Urgent Study about Its Use as an Adjuvant in Anti-SARS-CoV-2 Vaccines [Volume 7, Number 2] |
|
Bahramali, Golnaz
Engineering and Development of VP4-VP7 Rotavirus Fusion Protein in Pichia pastoris [Volume 7, Number 2] |
|
Aghasadeghi, Mohammad Reza
Engineering and Development of VP4-VP7 Rotavirus Fusion Protein in Pichia pastoris [Volume 7, Number 2] |
|
Mousavi-Nasab, Seyed Dawood
Engineering and Development of VP4-VP7 Rotavirus Fusion Protein in Pichia pastoris [Volume 7, Number 2] |
|
Kaghazian, Hooman
Engineering and Development of VP4-VP7 Rotavirus Fusion Protein in Pichia pastoris [Volume 7, Number 2] |
|
Amopour Bahnamiry, Mostafa
Engineering and Development of VP4-VP7 Rotavirus Fusion Protein in Pichia pastoris [Volume 7, Number 2] |
|
Mishra , Suruchi
Ethical Considerations and Challenges Duringthe COVID-19 Vaccine Deployment: Experiences from an Indian Perspective [Volume 7, Number 2] |
|
Basu, Saurav
Ethical Considerations and Challenges Duringthe COVID-19 Vaccine Deployment: Experiences from an Indian Perspective [Volume 7, Number 2] |
|
Ghodsian, Naser
Characterization and Inactivation of Infectious Bursal Disease Virus for Use as a Vaccine and Immunodiagnostic Reagent [Volume 7, Number 2] |
|
Shahsavandi, Shahla
Characterization and Inactivation of Infectious Bursal Disease Virus for Use as a Vaccine and Immunodiagnostic Reagent [Volume 7, Number 2] |
|
Ebrahimi, Mohammad Majid
Characterization and Inactivation of Infectious Bursal Disease Virus for Use as a Vaccine and Immunodiagnostic Reagent [Volume 7, Number 2] |
|
Madu, Chekwube
An Assessment of the 2017-2018 Post Measles Campaign Coverage Survey in the South-south Zone of Nigeria [Volume 7, Number 2] |
|
Orji, Jennie
An Assessment of the 2017-2018 Post Measles Campaign Coverage Survey in the South-south Zone of Nigeria [Volume 7, Number 2] |
|
Chime, Onyinye
An Assessment of the 2017-2018 Post Measles Campaign Coverage Survey in the South-south Zone of Nigeria [Volume 7, Number 2] |
|
Haghparast, Alireza
Combination of Chitosan and Myxovirus Resistance Oligonucleotide: An Efficient and Safe Natural Adjuvant against Influenza Virus [Volume 7, Number 2] |
|
Shahsavandi, Shahla
Combination of Chitosan and Myxovirus Resistance Oligonucleotide: An Efficient and Safe Natural Adjuvant against Influenza Virus [Volume 7, Number 2] |
|
Hashemi Tabar, Gholamreza
Combination of Chitosan and Myxovirus Resistance Oligonucleotide: An Efficient and Safe Natural Adjuvant against Influenza Virus [Volume 7, Number 2] |
|
Ahmadi, Maryam
Combination of Chitosan and Myxovirus Resistance Oligonucleotide: An Efficient and Safe Natural Adjuvant against Influenza Virus [Volume 7, Number 2] |
|
Mane, Abhay B
Determinants of Immunization Status Among Children Between 13-24 Months of Age in Maharashtra, India – A Community Based Cross-Sectional Study [Volume 7, Number 2] |
|
Gore, Harishchandra D
Determinants of Immunization Status Among Children Between 13-24 Months of Age in Maharashtra, India – A Community Based Cross-Sectional Study [Volume 7, Number 2] |
|
Gawade, Sachin A
Determinants of Immunization Status Among Children Between 13-24 Months of Age in Maharashtra, India – A Community Based Cross-Sectional Study [Volume 7, Number 2] |
|
Sadat, Seyed Mehdi
Murine Dendritic Cells for Immunotherapy and Vaccine Development: Generation, Optimization and Transduction [Volume 7, Number 2] |
|
Pouriayevali, Mohammad Hassan
Murine Dendritic Cells for Immunotherapy and Vaccine Development: Generation, Optimization and Transduction [Volume 7, Number 2] |
|
Bolhassani, Azam
Murine Dendritic Cells for Immunotherapy and Vaccine Development: Generation, Optimization and Transduction [Volume 7, Number 2] |
|
Ramezani, Amitis
Murine Dendritic Cells for Immunotherapy and Vaccine Development: Generation, Optimization and Transduction [Volume 7, Number 2] |
|
Mashhadi Abolghasem Shirazi, Maryam
Murine Dendritic Cells for Immunotherapy and Vaccine Development: Generation, Optimization and Transduction [Volume 7, Number 2] |
|
Larijani, Mona Sadat
Murine Dendritic Cells for Immunotherapy and Vaccine Development: Generation, Optimization and Transduction [Volume 7, Number 2] |
|
Dadras, Omid
Patients with COVID‐19‐Associated Hematologic Abnormalities and the Potential Role of the Cytokine Storm: A Case Series Study [Volume 7, Number 2] |
|
SeyedAlinaghi, SeyedAhmad
Patients with COVID‐19‐Associated Hematologic Abnormalities and the Potential Role of the Cytokine Storm: A Case Series Study [Volume 7, Number 2] |
|
Ghadimi, Fatemeh
Patients with COVID‐19‐Associated Hematologic Abnormalities and the Potential Role of the Cytokine Storm: A Case Series Study [Volume 7, Number 2] |
|
Barzegary, Alireza
Patients with COVID‐19‐Associated Hematologic Abnormalities and the Potential Role of the Cytokine Storm: A Case Series Study [Volume 7, Number 2] |
|
Seyedpour, Simin
Patients with COVID‐19‐Associated Hematologic Abnormalities and the Potential Role of the Cytokine Storm: A Case Series Study [Volume 7, Number 2] |
|
Hasibi, Mehrdad
Patients with COVID‐19‐Associated Hematologic Abnormalities and the Potential Role of the Cytokine Storm: A Case Series Study [Volume 7, Number 2] |
|
Ghiasvand, Fereshteh
Patients with COVID‐19‐Associated Hematologic Abnormalities and the Potential Role of the Cytokine Storm: A Case Series Study [Volume 7, Number 2] |
|
Asadollahi-Amin, Ali
Patients with COVID‐19‐Associated Hematologic Abnormalities and the Potential Role of the Cytokine Storm: A Case Series Study [Volume 7, Number 2] |
|
Thas, Olivier
Application of High Energy and Protein Diets in Combination with a Live Avirulent Escherichia coli F4 Vaccine Against Post-Weaning Diarrhea [Volume 7, Number 1] |
|
Vangroenweghe, Frédéric
Application of High Energy and Protein Diets in Combination with a Live Avirulent Escherichia coli F4 Vaccine Against Post-Weaning Diarrhea [Volume 7, Number 1] |
|
Sharma, Bhuvnesh Prasad
In silico study to predict and characterize of SARS CoV 2 Surface glycoprotein [Volume 7, Number 1] |
|
Kumar, Avnish
In silico study to predict and characterize of SARS CoV 2 Surface glycoprotein [Volume 7, Number 1] |
|
Arab Joshaghani , Abolfazl
Green Synthesized Silver Nanoparticles Using Anise (Pimpinella anisum L.) have Antibacterial Effects [Volume 7, Number 1] |
|
Bahramali , Golnaz
Green Synthesized Silver Nanoparticles Using Anise (Pimpinella anisum L.) have Antibacterial Effects [Volume 7, Number 1] |
|
Mirzaee , Mohsen
Green Synthesized Silver Nanoparticles Using Anise (Pimpinella anisum L.) have Antibacterial Effects [Volume 7, Number 1] |
|
Akhavan Sepahi , Abbas
Green Synthesized Silver Nanoparticles Using Anise (Pimpinella anisum L.) have Antibacterial Effects [Volume 7, Number 1] |
|
Siadat , Seyed Davar
Green Synthesized Silver Nanoparticles Using Anise (Pimpinella anisum L.) have Antibacterial Effects [Volume 7, Number 1] |
|
Rashnaei , Nassir
Green Synthesized Silver Nanoparticles Using Anise (Pimpinella anisum L.) have Antibacterial Effects [Volume 7, Number 1] |
|
Lundstrom, Kenneth
The Potential of Self-amplifying RNA Vaccines for Infectious Diseases and COVID-19 [Volume 7, Number 1] |
|
Kristina, Susi Ari
Parent’s Knowledge on Rotavirus Diarrhea and Vaccine in Indonesia [Volume 7, Number 1] |
|
Andayani, Tri Murti
Parent’s Knowledge on Rotavirus Diarrhea and Vaccine in Indonesia [Volume 7, Number 1] |
|
Endarti, Dwi
Parent’s Knowledge on Rotavirus Diarrhea and Vaccine in Indonesia [Volume 7, Number 1] |
|
Pratiwi, Arie Dwi
Parent’s Knowledge on Rotavirus Diarrhea and Vaccine in Indonesia [Volume 7, Number 1] |
|
Hamidi-Fard, Mojtaba
Purification of Functional HEV-ORF2 Protein from Inclusion Bodies for Vaccine and Diagnostic Applications [Volume 7, Number 1] |
|
Zaheri Birgani, Mohammad Ali
Purification of Functional HEV-ORF2 Protein from Inclusion Bodies for Vaccine and Diagnostic Applications [Volume 7, Number 1] |
|
Seyed Siamdoust, Seyed Alireza
Purification of Functional HEV-ORF2 Protein from Inclusion Bodies for Vaccine and Diagnostic Applications [Volume 7, Number 1] |
|
Fateh, Abolfazl
Purification of Functional HEV-ORF2 Protein from Inclusion Bodies for Vaccine and Diagnostic Applications [Volume 7, Number 1] |
|
Rahimi, Pooneh
Purification of Functional HEV-ORF2 Protein from Inclusion Bodies for Vaccine and Diagnostic Applications [Volume 7, Number 1] |
|
Moravej, Seyede Zahra
Purification of Functional HEV-ORF2 Protein from Inclusion Bodies for Vaccine and Diagnostic Applications [Volume 7, Number 1] |
|
Sardari, Soroush
Purification of Functional HEV-ORF2 Protein from Inclusion Bodies for Vaccine and Diagnostic Applications [Volume 7, Number 1] |
|
Bahramali, Golnaz
Purification of Functional HEV-ORF2 Protein from Inclusion Bodies for Vaccine and Diagnostic Applications [Volume 7, Number 1] |
|
Etemadzadeh, Mazyar
Purification of Functional HEV-ORF2 Protein from Inclusion Bodies for Vaccine and Diagnostic Applications [Volume 7, Number 1] |
|
Amiran, Mohammad Reza
Purification of Functional HEV-ORF2 Protein from Inclusion Bodies for Vaccine and Diagnostic Applications [Volume 7, Number 1] |
|
Motevalli, Fatemeh
Purification of Functional HEV-ORF2 Protein from Inclusion Bodies for Vaccine and Diagnostic Applications [Volume 7, Number 1] |
|
Méndez-Samperio, Patricia
The Importance of Group 2 Innate Lymphoid Cells to Improve the Protective Immunity in Parasitic Helminth Infections [Volume 7, Number 1] |
|
Mousavi, Seyed fazlollah
Assessment of PhtD C-Terminal Immunogenicity by Opsonophagocytosis Assay (OPA) with OMVs as Adjuvants [Volume 6, Number 2] |
|
Afshari, Elnaz
Assessment of PhtD C-Terminal Immunogenicity by Opsonophagocytosis Assay (OPA) with OMVs as Adjuvants [Volume 6, Number 2] |
|
Eybpoosh, Sana
Assessment of PhtD C-Terminal Immunogenicity by Opsonophagocytosis Assay (OPA) with OMVs as Adjuvants [Volume 6, Number 2] |
|
Shahrokhi, Nader
Assessment of PhtD C-Terminal Immunogenicity by Opsonophagocytosis Assay (OPA) with OMVs as Adjuvants [Volume 6, Number 2] |
|
Aghasadeghi, Mohammadreza
Assessment of PhtD C-Terminal Immunogenicity by Opsonophagocytosis Assay (OPA) with OMVs as Adjuvants [Volume 6, Number 2] |
|
Siadat, Seyed Davar
Assessment of PhtD C-Terminal Immunogenicity by Opsonophagocytosis Assay (OPA) with OMVs as Adjuvants [Volume 6, Number 2] |
|
Malekan, Mohammadali
Assessment of PhtD C-Terminal Immunogenicity by Opsonophagocytosis Assay (OPA) with OMVs as Adjuvants [Volume 6, Number 2] |
|
ebrahimi, mohammad majid
Evaluation of the Effects of Chitosan on Immune Responses due to Infectious Bursal Disease Virus (IBDV) Vaccine in Chicken [Volume 6, Number 2] |
|
Shahsavandi, Shahla
Evaluation of the Effects of Chitosan on Immune Responses due to Infectious Bursal Disease Virus (IBDV) Vaccine in Chicken [Volume 6, Number 2] |
|
Armandei, Sadi
Evaluation of the Effects of Chitosan on Immune Responses due to Infectious Bursal Disease Virus (IBDV) Vaccine in Chicken [Volume 6, Number 2] |
|
Das, P
A Community Based Cohort Study on Usefulness of Leishmanin Skin Test in Detection of Immunoreactivity Against Leishmania donovani Infection in an Endemic Area of Kala-Azar, Bihar, India [Volume 6, Number 2] |
|
Kar, Shantanu
A Community Based Cohort Study on Usefulness of Leishmanin Skin Test in Detection of Immunoreactivity Against Leishmania donovani Infection in an Endemic Area of Kala-Azar, Bihar, India [Volume 6, Number 2] |
|
Rabidas, Vidya Nand
A Community Based Cohort Study on Usefulness of Leishmanin Skin Test in Detection of Immunoreactivity Against Leishmania donovani Infection in an Endemic Area of Kala-Azar, Bihar, India [Volume 6, Number 2] |
|
Pandey, K
A Community Based Cohort Study on Usefulness of Leishmanin Skin Test in Detection of Immunoreactivity Against Leishmania donovani Infection in an Endemic Area of Kala-Azar, Bihar, India [Volume 6, Number 2] |
|
Verma, Rakesh
A Community Based Cohort Study on Usefulness of Leishmanin Skin Test in Detection of Immunoreactivity Against Leishmania donovani Infection in an Endemic Area of Kala-Azar, Bihar, India [Volume 6, Number 2] |
|
Ranjan, Alok
A Community Based Cohort Study on Usefulness of Leishmanin Skin Test in Detection of Immunoreactivity Against Leishmania donovani Infection in an Endemic Area of Kala-Azar, Bihar, India [Volume 6, Number 2] |
|
Lal, Chandra
A Community Based Cohort Study on Usefulness of Leishmanin Skin Test in Detection of Immunoreactivity Against Leishmania donovani Infection in an Endemic Area of Kala-Azar, Bihar, India [Volume 6, Number 2] |
|
Gupta Anil, Kumar
A Community Based Cohort Study on Usefulness of Leishmanin Skin Test in Detection of Immunoreactivity Against Leishmania donovani Infection in an Endemic Area of Kala-Azar, Bihar, India [Volume 6, Number 2] |
|
Bimal, Sanjiva
A Community Based Cohort Study on Usefulness of Leishmanin Skin Test in Detection of Immunoreactivity Against Leishmania donovani Infection in an Endemic Area of Kala-Azar, Bihar, India [Volume 6, Number 2] |
|
Verma, Neena
A Community Based Cohort Study on Usefulness of Leishmanin Skin Test in Detection of Immunoreactivity Against Leishmania donovani Infection in an Endemic Area of Kala-Azar, Bihar, India [Volume 6, Number 2] |
|
Babaei, Ryhaneh
Putative Targets as Vaccine Candidates with Respect to Biofilm Formation Procedure in Staphylococci [Volume 6, Number 2] |
|
Goli, HamidReza
Putative Targets as Vaccine Candidates with Respect to Biofilm Formation Procedure in Staphylococci [Volume 6, Number 2] |
|
Haghshenas, Mohammad Reza
Putative Targets as Vaccine Candidates with Respect to Biofilm Formation Procedure in Staphylococci [Volume 6, Number 2] |
|
Mirzaei, Bahman
Putative Targets as Vaccine Candidates with Respect to Biofilm Formation Procedure in Staphylococci [Volume 6, Number 2] |
|
Wang, Chongzhen
Effects of Microgravity on the Monocyte/Macrophage Physiology and the Potential Implication in Immune Responses to Vaccines [Volume 6, Number 2] |
|
Xing , Wanlin
Effects of Microgravity on the Monocyte/Macrophage Physiology and the Potential Implication in Immune Responses to Vaccines [Volume 6, Number 2] |
|
Yang , Jiawei
Effects of Microgravity on the Monocyte/Macrophage Physiology and the Potential Implication in Immune Responses to Vaccines [Volume 6, Number 2] |
|
Antony, Joseph
Immunobiological Correlates of SIV Vaccine Vectors and Macaque Tropism [Volume 6, Number 2] |
|
Aghasadeghi, Mohammad Reza
Prospective on Different Approaches for Vaccine Development Against COVID-19: Past Lessons and Future Challenges [Volume 6, Number 2] |
|
Rhimi, Pooneh
Prospective on Different Approaches for Vaccine Development Against COVID-19: Past Lessons and Future Challenges [Volume 6, Number 2] |
|
El Ridi, Rashika
Immunogenicity and Protective Capacity of Schistosoma haematobium Recombinant cathepsin L Against Infection of Hamsters with S. haematobium [Volume 6, Number 2] |
|
Abou El Dahab, Marwa
Immunogenicity and Protective Capacity of Schistosoma haematobium Recombinant cathepsin L Against Infection of Hamsters with S. haematobium [Volume 6, Number 2] |
|
Tallima, Hatem
Immunogenicity and Protective Capacity of Schistosoma haematobium Recombinant cathepsin L Against Infection of Hamsters with S. haematobium [Volume 6, Number 2] |
|
Abdel Aziz, Nada
Immunogenicity and Protective Capacity of Schistosoma haematobium Recombinant cathepsin L Against Infection of Hamsters with S. haematobium [Volume 6, Number 2] |
|
Ehsani, Parastoo
Design and Expression Optimization of a Chimeric Derivative of NetB, Alpha-Toxin and Metallopeptidase Proteins as a Subunit Vaccine Against Clostridium perfringens [Volume 6, Number 1] |
|
Kiani, Ghafar
Design and Expression Optimization of a Chimeric Derivative of NetB, Alpha-Toxin and Metallopeptidase Proteins as a Subunit Vaccine Against Clostridium perfringens [Volume 6, Number 1] |
|
Amani, Jafar
Design and Expression Optimization of a Chimeric Derivative of NetB, Alpha-Toxin and Metallopeptidase Proteins as a Subunit Vaccine Against Clostridium perfringens [Volume 6, Number 1] |
|
Ahmadian, Gholamreza
Design and Expression Optimization of a Chimeric Derivative of NetB, Alpha-Toxin and Metallopeptidase Proteins as a Subunit Vaccine Against Clostridium perfringens [Volume 6, Number 1] |
|
Nematzadeh, Ghorbanali
Design and Expression Optimization of a Chimeric Derivative of NetB, Alpha-Toxin and Metallopeptidase Proteins as a Subunit Vaccine Against Clostridium perfringens [Volume 6, Number 1] |
|
Katalani, Camellia
Design and Expression Optimization of a Chimeric Derivative of NetB, Alpha-Toxin and Metallopeptidase Proteins as a Subunit Vaccine Against Clostridium perfringens [Volume 6, Number 1] |
|
Siadat, Seyed Davar
Comparison of Outer Membrane Vesicles of Three Different Isolates from Pseudomonas aeruginosa [Volume 6, Number 1] |
|
Vaziri, Farzam
Comparison of Outer Membrane Vesicles of Three Different Isolates from Pseudomonas aeruginosa [Volume 6, Number 1] |
|
Nejadsattari, Taher
Comparison of Outer Membrane Vesicles of Three Different Isolates from Pseudomonas aeruginosa [Volume 6, Number 1] |
|
Satarian, Fereshteh
Comparison of Outer Membrane Vesicles of Three Different Isolates from Pseudomonas aeruginosa [Volume 6, Number 1] |
|
Shahcheraghi, Fereshteh
Seroepidemiology of Pertussis in a Set of Under One Year Old Iranian Children [Volume 6, Number 1] |
|
Siadat, Seyed Davar
Seroepidemiology of Pertussis in a Set of Under One Year Old Iranian Children [Volume 6, Number 1] |
|
Badamchi, Ali
Seroepidemiology of Pertussis in a Set of Under One Year Old Iranian Children [Volume 6, Number 1] |
|
Arefian, Ehsan
Modification of SPION Nanocarriers for siRNA Delivery: A Therapeutic Strategy Against HIV Infection [Volume 6, Number 1] |
|
Bolhassani, Azam
Modification of SPION Nanocarriers for siRNA Delivery: A Therapeutic Strategy Against HIV Infection [Volume 6, Number 1] |
|
Rahimi, Pooneh
Modification of SPION Nanocarriers for siRNA Delivery: A Therapeutic Strategy Against HIV Infection [Volume 6, Number 1] |
|
Modarressi, Mohammad Hossein
Modification of SPION Nanocarriers for siRNA Delivery: A Therapeutic Strategy Against HIV Infection [Volume 6, Number 1] |
|
Mobarakeh, Vahid
Modification of SPION Nanocarriers for siRNA Delivery: A Therapeutic Strategy Against HIV Infection [Volume 6, Number 1] |
|
mostafavi, ehsan
Pasteur Institute of Iran; a Leading Institute in the Production and Development of Vaccines in Iran [Volume 6, Number 1] |
|
Doroud, Delaram
Pasteur Institute of Iran; a Leading Institute in the Production and Development of Vaccines in Iran [Volume 6, Number 1] |
|
Maslehat, Sholeh
Pasteur Institute of Iran; a Leading Institute in the Production and Development of Vaccines in Iran [Volume 6, Number 1] |
|
Méndez-Samperio, Patricia
The Current Status of Bacillus Calmette‐Guérin Vaccine Protective Efficacy [Volume 6, Number 1] |
|
Rudenko, Larisa
Could Trivalent LAIV Protect Against Both Genetic Lineages of Influenza B Virus? [Volume 6, Number 1] |
|
Grigorieva, Elena
Could Trivalent LAIV Protect Against Both Genetic Lineages of Influenza B Virus? [Volume 6, Number 1] |
|
Muzhikyan, Arman
Could Trivalent LAIV Protect Against Both Genetic Lineages of Influenza B Virus? [Volume 6, Number 1] |
|
Kryshen, Kirill
Could Trivalent LAIV Protect Against Both Genetic Lineages of Influenza B Virus? [Volume 6, Number 1] |
|
Katelnikova, Anastasia
Could Trivalent LAIV Protect Against Both Genetic Lineages of Influenza B Virus? [Volume 6, Number 1] |
|
Pisareva, Maria
Could Trivalent LAIV Protect Against Both Genetic Lineages of Influenza B Virus? [Volume 6, Number 1] |
|
Bazhenova, Ekaterina
Could Trivalent LAIV Protect Against Both Genetic Lineages of Influenza B Virus? [Volume 6, Number 1] |
|
Rekstin, Andrey
Could Trivalent LAIV Protect Against Both Genetic Lineages of Influenza B Virus? [Volume 6, Number 1] |
|
Donina, Svetlana
Could Trivalent LAIV Protect Against Both Genetic Lineages of Influenza B Virus? [Volume 6, Number 1] |
|
Krutikova, Elena
Could Trivalent LAIV Protect Against Both Genetic Lineages of Influenza B Virus? [Volume 6, Number 1] |
|
Stepanova, Ekaterina
Could Trivalent LAIV Protect Against Both Genetic Lineages of Influenza B Virus? [Volume 6, Number 1] |
|
Kiseleva, Irina
Could Trivalent LAIV Protect Against Both Genetic Lineages of Influenza B Virus? [Volume 6, Number 1] |
|
Kaghazian, H
Rotavirus infection in Iran and current vaccines against it [Volume 5, Number 2] |
|
Mousavi-Nasab, SD
Rotavirus infection in Iran and current vaccines against it [Volume 5, Number 2] |
|
Alimohammadian , MH
Comparison of cell-mediated immunity due to Leishmania infantum promastigotes and axenic amastigotes [Volume 5, Number 2] |
|
Darabi , H
Comparison of cell-mediated immunity due to Leishmania infantum promastigotes and axenic amastigotes [Volume 5, Number 2] |
|
Khaze , V
Comparison of cell-mediated immunity due to Leishmania infantum promastigotes and axenic amastigotes [Volume 5, Number 2] |
|
Ajdary , S
Comparison of cell-mediated immunity due to Leishmania infantum promastigotes and axenic amastigotes [Volume 5, Number 2] |
|
Najafi-Dastanaei , A
Comparison of cell-mediated immunity due to Leishmania infantum promastigotes and axenic amastigotes [Volume 5, Number 2] |
|
Yasri , S
Free vaccinations and clinical history takings of the vaccine recipients: reliable or not? [Volume 5, Number 1] |
|
Wiwanitkit , V
Free vaccinations and clinical history takings of the vaccine recipients: reliable or not? [Volume 5, Number 1] |
|
Siadat , SD
A polyethylene glycol-based method for extraction of extracellular vesicles from Lactobacillus casei as vaccine delivery vehicle [Volume 5, Number 2] |
|
Vaziri , F
A polyethylene glycol-based method for extraction of extracellular vesicles from Lactobacillus casei as vaccine delivery vehicle [Volume 5, Number 2] |
|
Motevaseli , E
A polyethylene glycol-based method for extraction of extracellular vesicles from Lactobacillus casei as vaccine delivery vehicle [Volume 5, Number 2] |
|
Modarressi , MH
A polyethylene glycol-based method for extraction of extracellular vesicles from Lactobacillus casei as vaccine delivery vehicle [Volume 5, Number 2] |
|
Ebrahimi Vargoorani , M
A polyethylene glycol-based method for extraction of extracellular vesicles from Lactobacillus casei as vaccine delivery vehicle [Volume 5, Number 2] |
|
Shahcheraghi , F
Determination of bactericidal activity of serum against Vibrio cholerae outer membrane vesicles in BALB/c mice [Volume 5, Number 2] |
|
Vaziri, F
Determination of bactericidal activity of serum against Vibrio cholerae outer membrane vesicles in BALB/c mice [Volume 5, Number 2] |
|
Keramati , M
Determination of bactericidal activity of serum against Vibrio cholerae outer membrane vesicles in BALB/c mice [Volume 5, Number 2] |
|
Mirabzadeh Ardakani , E
Determination of bactericidal activity of serum against Vibrio cholerae outer membrane vesicles in BALB/c mice [Volume 5, Number 2] |
|
Siadat, SD
Determination of bactericidal activity of serum against Vibrio cholerae outer membrane vesicles in BALB/c mice [Volume 5, Number 2] |
|
Sedaghat , M
Determination of bactericidal activity of serum against Vibrio cholerae outer membrane vesicles in BALB/c mice [Volume 5, Number 2] |
|
Shahcheraghi , F
Characterization of a predominant Bordetella pertussis strain isolated from Iranian patients [Volume 5, Number 2] |
|
Shams Nosrati , MS
Characterization of a predominant Bordetella pertussis strain isolated from Iranian patients [Volume 5, Number 2] |
|
Bolourchi , N
Characterization of a predominant Bordetella pertussis strain isolated from Iranian patients [Volume 5, Number 2] |
|
Noofeli , M
Characterization of a predominant Bordetella pertussis strain isolated from Iranian patients [Volume 5, Number 2] |
|
Keramati , M
Characterization of a predominant Bordetella pertussis strain isolated from Iranian patients [Volume 5, Number 2] |
|
Nikbin , VS
Characterization of a predominant Bordetella pertussis strain isolated from Iranian patients [Volume 5, Number 2] |
|
Mohebati Mobarez , A
A streamlined method for the extraction of outer membrane vesicles (OMVs) from Bordetella pertussis [Volume 5, Number 2] |
|
Noofeli , M
A streamlined method for the extraction of outer membrane vesicles (OMVs) from Bordetella pertussis [Volume 5, Number 2] |
|
Siadat , SD
A streamlined method for the extraction of outer membrane vesicles (OMVs) from Bordetella pertussis [Volume 5, Number 2] |
|
Sekhavati , M
A streamlined method for the extraction of outer membrane vesicles (OMVs) from Bordetella pertussis [Volume 5, Number 2] |
|
Wiwanitkit , V
Prediction of the rate of children prone to diphtheria infection in a Laos remote area: A reappraisal on seroepidemiology data during a major diphtheria outbreak in 2012 [Volume 5, Number 2] |
|
Wiwanitkit , S
Prediction of the rate of children prone to diphtheria infection in a Laos remote area: A reappraisal on seroepidemiology data during a major diphtheria outbreak in 2012 [Volume 5, Number 2] |
|
Parsamanesh, M
The role of vaccination in controlling the outbreak of infectious diseases: a mathematical approach [Volume 5, Number 1] |
|
Siadat , SD
Comparison of two isolation methods for extracellular vesicles from Faecalibacterium prausnitzii A2-165 [Volume 5, Number 1] |
|
Vaziri , F
Comparison of two isolation methods for extracellular vesicles from Faecalibacterium prausnitzii A2-165 [Volume 5, Number 1] |
|
Nejad Sattari , T
Comparison of two isolation methods for extracellular vesicles from Faecalibacterium prausnitzii A2-165 [Volume 5, Number 1] |
|
Ettehad Marvasti, F
Comparison of two isolation methods for extracellular vesicles from Faecalibacterium prausnitzii A2-165 [Volume 5, Number 1] |
|
Ahmadi Badi, S
Comparison of two isolation methods for extracellular vesicles from Faecalibacterium prausnitzii A2-165 [Volume 5, Number 1] |
|
Rabiei , N
Comparison of two isolation methods for extracellular vesicles from Faecalibacterium prausnitzii A2-165 [Volume 5, Number 1] |
|
Hamidi-Fard, M
Cloning and expression of hepatitis E virus ORF2 as an immunogen protein in baculovirus expression system [Volume 5, Number 1] |
|
Mohammadi Pargoo , S
Cloning and expression of hepatitis E virus ORF2 as an immunogen protein in baculovirus expression system [Volume 5, Number 1] |
|
Amiran , MR
Cloning and expression of hepatitis E virus ORF2 as an immunogen protein in baculovirus expression system [Volume 5, Number 1] |
|
Motevalli , F
Cloning and expression of hepatitis E virus ORF2 as an immunogen protein in baculovirus expression system [Volume 5, Number 1] |
|
Aghasadeghi , MR
Cloning and expression of hepatitis E virus ORF2 as an immunogen protein in baculovirus expression system [Volume 5, Number 1] |
|
Shahanaghi , M
Cloning and expression of hepatitis E virus ORF2 as an immunogen protein in baculovirus expression system [Volume 5, Number 1] |
|
Sadeghi , SA
Cloning and expression of hepatitis E virus ORF2 as an immunogen protein in baculovirus expression system [Volume 5, Number 1] |
|
Soleimani , S
Enhancement of cell-mediated immune response in chickens by combination of TIR-TLR7 with inactivated Newcastle disease vaccine [Volume 5, Number 1] |
|
Ebrahimi , MM
Enhancement of cell-mediated immune response in chickens by combination of TIR-TLR7 with inactivated Newcastle disease vaccine [Volume 5, Number 1] |
|
Shahsavandi , S
Enhancement of cell-mediated immune response in chickens by combination of TIR-TLR7 with inactivated Newcastle disease vaccine [Volume 5, Number 1] |
|
Rashid , S
Enhancement of cell-mediated immune response in chickens by combination of TIR-TLR7 with inactivated Newcastle disease vaccine [Volume 5, Number 1] |
|
Asadi Karam , MR
Cloning and expression of PMI1945 involved in iron acquisition as a promising vaccine candidate against Proteus mirabilis [Volume 5, Number 1] |
|
Sari , S
Cloning and expression of PMI1945 involved in iron acquisition as a promising vaccine candidate against Proteus mirabilis [Volume 5, Number 1] |
|
Habibi , M
Cloning and expression of PMI1945 involved in iron acquisition as a promising vaccine candidate against Proteus mirabilis [Volume 5, Number 1] |
|
Kavehei , B
Cloning and expression of PMI1945 involved in iron acquisition as a promising vaccine candidate against Proteus mirabilis [Volume 5, Number 1] |
|
Azarnoosh , M
Challenge-based approaches for policy-making in vaccine development and production [Volume 5, Number 1] |
|
Jafari , P
Challenge-based approaches for policy-making in vaccine development and production [Volume 5, Number 1] |
|
Tabatabaeian , SH
Challenge-based approaches for policy-making in vaccine development and production [Volume 5, Number 1] |
|
Marandi , V
Challenge-based approaches for policy-making in vaccine development and production [Volume 5, Number 1] |
|
Siadat, SD
PorA typing of Neisseria meningitidis isolates from Iranian children for vaccine design [Volume 5, Number 1] |
|
Mardani , G
PorA typing of Neisseria meningitidis isolates from Iranian children for vaccine design [Volume 5, Number 1] |
|
Behrouzi , A
PorA typing of Neisseria meningitidis isolates from Iranian children for vaccine design [Volume 5, Number 1] |
|
Asadi Karam, MR
PorA typing of Neisseria meningitidis isolates from Iranian children for vaccine design [Volume 5, Number 1] |
|
Vosogh , M
PorA typing of Neisseria meningitidis isolates from Iranian children for vaccine design [Volume 5, Number 1] |
|
Afrough, P
PorA typing of Neisseria meningitidis isolates from Iranian children for vaccine design [Volume 5, Number 1] |
|
Akbary , N
Lactococcus lactis as a live delivery vector [Volume 3, Number 3] |
|
Jafari , P
Lactococcus lactis as a live delivery vector [Volume 3, Number 3] |
|
Hosseini , SD
Lactococcus lactis as a live delivery vector [Volume 3, Number 3] |
|
Azizpour , M
Lactococcus lactis as a live delivery vector [Volume 3, Number 3] |
|
Azarnoosh , M
Vaccine production industry in Iran and the necessity for policy coherence [Volume 4, Number 3] |
|
Jafari, P
Vaccine production industry in Iran and the necessity for policy coherence [Volume 4, Number 3] |
|
Tabatabaeian , SH
Vaccine production industry in Iran and the necessity for policy coherence [Volume 4, Number 3] |
|
Marandi , V
Vaccine production industry in Iran and the necessity for policy coherence [Volume 4, Number 3] |
|
Hamidi-Fard , M
Cloning and expression of hepatitis E virus ORF2 as a vaccine candidate [Volume 4, Number 3] |
|
Motevalli, F
Cloning and expression of hepatitis E virus ORF2 as a vaccine candidate [Volume 4, Number 3] |
|
Divbandi, M
Cloning and expression of hepatitis E virus ORF2 as a vaccine candidate [Volume 4, Number 3] |
|
Shahbazi, S
Cloning and expression of hepatitis E virus ORF2 as a vaccine candidate [Volume 4, Number 3] |
|
Moravej, SZ
Cloning and expression of hepatitis E virus ORF2 as a vaccine candidate [Volume 4, Number 3] |
|
Ghanei, M
Cloning and expression of hepatitis E virus ORF2 as a vaccine candidate [Volume 4, Number 3] |
|
Owlia , P
Cloning and expression of hepatitis E virus ORF2 as a vaccine candidate [Volume 4, Number 3] |
|
Rahimi, P
Cloning and expression of hepatitis E virus ORF2 as a vaccine candidate [Volume 4, Number 3] |
|
Bahramali , G
Cloning and expression of hepatitis E virus ORF2 as a vaccine candidate [Volume 4, Number 3] |
|
Amiran , MR
Cloning and expression of hepatitis E virus ORF2 as a vaccine candidate [Volume 4, Number 3] |
|
Aghasadeghi , MR
Cloning and expression of hepatitis E virus ORF2 as a vaccine candidate [Volume 4, Number 3] |
|
Sadeghi , SA
Cloning and expression of hepatitis E virus ORF2 as a vaccine candidate [Volume 4, Number 3] |
|
Ehsani , P
Transient expression of virus-like particles in plants: a promising platform for rapid vaccine production [Volume 4, Number 3] |
|
Ofoghi , H
Transient expression of virus-like particles in plants: a promising platform for rapid vaccine production [Volume 4, Number 3] |
|
Ebrahimi-Rad , M
Transient expression of virus-like particles in plants: a promising platform for rapid vaccine production [Volume 4, Number 3] |
|
Rahimi , S
Transient expression of virus-like particles in plants: a promising platform for rapid vaccine production [Volume 4, Number 3] |
|
Mohammadzadeh , S
Transient expression of virus-like particles in plants: a promising platform for rapid vaccine production [Volume 4, Number 3] |
|
Badmasti , F
Comparative in silico analyses of proteins involved in serum resistance as promising vaccine candidates against Acinetobacter baumannii [Volume 4, Number 3] |
|
Aghamohammad , Sh
Comparative in silico analyses of proteins involved in serum resistance as promising vaccine candidates against Acinetobacter baumannii [Volume 4, Number 3] |
|
Bolourchi , N
Comparative in silico analyses of proteins involved in serum resistance as promising vaccine candidates against Acinetobacter baumannii [Volume 4, Number 3] |
|
Azizi , O
Comparative in silico analyses of proteins involved in serum resistance as promising vaccine candidates against Acinetobacter baumannii [Volume 4, Number 3] |
|
Soltani Shirazi , A
Comparative in silico analyses of proteins involved in serum resistance as promising vaccine candidates against Acinetobacter baumannii [Volume 4, Number 3] |
|
El-Rashidy , FH
Constructions of hepatitis C Virus prophylactic vaccine candidate using Berberis vulgaris stimulated and nonstructural protein 3 loaded dendritic cells [Volume 4, Number 3] |
|
El-Demella , MA
Constructions of hepatitis C Virus prophylactic vaccine candidate using Berberis vulgaris stimulated and nonstructural protein 3 loaded dendritic cells [Volume 4, Number 3] |
|
Habashy , NH
Constructions of hepatitis C Virus prophylactic vaccine candidate using Berberis vulgaris stimulated and nonstructural protein 3 loaded dendritic cells [Volume 4, Number 3] |
|
Shaban , NZ
Constructions of hepatitis C Virus prophylactic vaccine candidate using Berberis vulgaris stimulated and nonstructural protein 3 loaded dendritic cells [Volume 4, Number 3] |
|
Ghareeb, DA
Constructions of hepatitis C Virus prophylactic vaccine candidate using Berberis vulgaris stimulated and nonstructural protein 3 loaded dendritic cells [Volume 4, Number 3] |
|
Siadat, SD
Isolation and characterization of Faecalibacterium prausnitzii extracellular vesicles [Volume 4, Number 3] |
|
Vaziri , F
Isolation and characterization of Faecalibacterium prausnitzii extracellular vesicles [Volume 4, Number 3] |
|
Khavari Nejad , RA
Isolation and characterization of Faecalibacterium prausnitzii extracellular vesicles [Volume 4, Number 3] |
|
Jafari , B
Isolation and characterization of Faecalibacterium prausnitzii extracellular vesicles [Volume 4, Number 3] |
|
Arashkia , A
Human papillomavirus genotype 16 pseudovirus production and purification in HEK-293FT cells [Volume 4, Number 3] |
|
Azadmanesh , K
Human papillomavirus genotype 16 pseudovirus production and purification in HEK-293FT cells [Volume 4, Number 3] |
|
Langroudi , L
Human papillomavirus genotype 16 pseudovirus production and purification in HEK-293FT cells [Volume 4, Number 3] |
|
Sharifi , H
Human papillomavirus genotype 16 pseudovirus production and purification in HEK-293FT cells [Volume 4, Number 3] |
|
Barzegar , H
Human papillomavirus genotype 16 pseudovirus production and purification in HEK-293FT cells [Volume 4, Number 3] |
|
Vahabpour , R
Immunization with cytomegalovirus gB protein produced by the Baculovirus Expression Vector System to elicit humoral immune response in BALB/c mice [Volume 4, Number 1] |
|
Shahmehri , M
Immunization with cytomegalovirus gB protein produced by the Baculovirus Expression Vector System to elicit humoral immune response in BALB/c mice [Volume 4, Number 1] |
|
Aghasadeghi, MR
Immunization with cytomegalovirus gB protein produced by the Baculovirus Expression Vector System to elicit humoral immune response in BALB/c mice [Volume 4, Number 1] |
|
Jalali , F
Immunization with cytomegalovirus gB protein produced by the Baculovirus Expression Vector System to elicit humoral immune response in BALB/c mice [Volume 4, Number 1] |
|
Asiyabi , S
Immunization with cytomegalovirus gB protein produced by the Baculovirus Expression Vector System to elicit humoral immune response in BALB/c mice [Volume 4, Number 1] |
|
Azizi Saraji , A
Immunization with cytomegalovirus gB protein produced by the Baculovirus Expression Vector System to elicit humoral immune response in BALB/c mice [Volume 4, Number 1] |
|
Jalili , N
Cloning, expression and purification of hemagglutinin conserved domain (HA2) of influenza A virus, to be used in broad-spectrum subunit vaccine cocktails [Volume 4, Number 1] |
|
Mehrbod , P
Cloning, expression and purification of hemagglutinin conserved domain (HA2) of influenza A virus, to be used in broad-spectrum subunit vaccine cocktails [Volume 4, Number 1] |
|
Fotouhi Chahouki , F
Cloning, expression and purification of hemagglutinin conserved domain (HA2) of influenza A virus, to be used in broad-spectrum subunit vaccine cocktails [Volume 4, Number 1] |
|
Akbari , Kh
Cloning, expression and purification of hemagglutinin conserved domain (HA2) of influenza A virus, to be used in broad-spectrum subunit vaccine cocktails [Volume 4, Number 1] |
|
Akbari , A
Cloning, expression and purification of hemagglutinin conserved domain (HA2) of influenza A virus, to be used in broad-spectrum subunit vaccine cocktails [Volume 4, Number 1] |
|
Farahmand , B
Cloning, expression and purification of hemagglutinin conserved domain (HA2) of influenza A virus, to be used in broad-spectrum subunit vaccine cocktails [Volume 4, Number 1] |
|
Arashkia , A
Preparation and in vivo anti-tumor evaluation of human papillomavirus E7 adjuvanted with Montanide ISA 266 as a vaccine candidate [Volume 4, Number 1] |
|
Roohvand , F
Preparation and in vivo anti-tumor evaluation of human papillomavirus E7 adjuvanted with Montanide ISA 266 as a vaccine candidate [Volume 4, Number 1] |
|
Mashhadi Abolghasem Shirazi , M
Preparation and in vivo anti-tumor evaluation of human papillomavirus E7 adjuvanted with Montanide ISA 266 as a vaccine candidate [Volume 4, Number 1] |
|
Aghasadeghi, MR
Design and construction of Beclin1-expressing plasmid as an autophagy inducing system: a novel strategy for enhancing the potency of DNA vaccines [Volume 4, Number 1] |
|
Amiran, MR
Design and construction of Beclin1-expressing plasmid as an autophagy inducing system: a novel strategy for enhancing the potency of DNA vaccines [Volume 4, Number 1] |
|
Khateri , M
Design and construction of Beclin1-expressing plasmid as an autophagy inducing system: a novel strategy for enhancing the potency of DNA vaccines [Volume 4, Number 1] |
|
Yavarian , J
Design and construction of Beclin1-expressing plasmid as an autophagy inducing system: a novel strategy for enhancing the potency of DNA vaccines [Volume 4, Number 1] |
|
Motevalli, F
Design and construction of Beclin1-expressing plasmid as an autophagy inducing system: a novel strategy for enhancing the potency of DNA vaccines [Volume 4, Number 1] |
|
Tahmtan , A
Design and construction of Beclin1-expressing plasmid as an autophagy inducing system: a novel strategy for enhancing the potency of DNA vaccines [Volume 4, Number 1] |
|
Abdoli , A
Design and construction of Beclin1-expressing plasmid as an autophagy inducing system: a novel strategy for enhancing the potency of DNA vaccines [Volume 4, Number 1] |
|
Naziri , H
Design and construction of Beclin1-expressing plasmid as an autophagy inducing system: a novel strategy for enhancing the potency of DNA vaccines [Volume 4, Number 1] |
|
Siadat , SD
Extraction and biological evaluation of Mycobacterium kansasii extracellular vesicles as a vaccine candidate against mycobacterial pulmonary infections [Volume 4, Number 1] |
|
Vaziri , F
Extraction and biological evaluation of Mycobacterium kansasii extracellular vesicles as a vaccine candidate against mycobacterial pulmonary infections [Volume 4, Number 1] |
|
Hoseini Tavassol , Z
Extraction and biological evaluation of Mycobacterium kansasii extracellular vesicles as a vaccine candidate against mycobacterial pulmonary infections [Volume 4, Number 1] |
|
Tohidi, F
Preparation and characterization of PLGA Nanoparticles containing recombinant core-NS3 Fusion protein of hepatitis C virus as a nano-vaccine candidate [Volume 4, Number 1] |
|
Ghahari , SMM
Preparation and characterization of PLGA Nanoparticles containing recombinant core-NS3 Fusion protein of hepatitis C virus as a nano-vaccine candidate [Volume 4, Number 1] |
|
Asgarhalvaee , F
Preparation and characterization of PLGA Nanoparticles containing recombinant core-NS3 Fusion protein of hepatitis C virus as a nano-vaccine candidate [Volume 4, Number 1] |
|
Shahbazi, S
Preparation and characterization of PLGA Nanoparticles containing recombinant core-NS3 Fusion protein of hepatitis C virus as a nano-vaccine candidate [Volume 4, Number 1] |
|
Mahdavi , M
Preparation and characterization of PLGA Nanoparticles containing recombinant core-NS3 Fusion protein of hepatitis C virus as a nano-vaccine candidate [Volume 4, Number 1] |
|
Sadat, SM
Preparation and characterization of PLGA Nanoparticles containing recombinant core-NS3 Fusion protein of hepatitis C virus as a nano-vaccine candidate [Volume 4, Number 1] |
|
Siadat , SD
Preparation and characterization of PLGA Nanoparticles containing recombinant core-NS3 Fusion protein of hepatitis C virus as a nano-vaccine candidate [Volume 4, Number 1] |
|
Aghasadeghi, MR
Preparation and characterization of PLGA Nanoparticles containing recombinant core-NS3 Fusion protein of hepatitis C virus as a nano-vaccine candidate [Volume 4, Number 1] |
|
Shafiee Ardestani , M
Preparation and characterization of PLGA Nanoparticles containing recombinant core-NS3 Fusion protein of hepatitis C virus as a nano-vaccine candidate [Volume 4, Number 1] |
|
Aslani , MM
Preparation and characterization of PLGA Nanoparticles containing recombinant core-NS3 Fusion protein of hepatitis C virus as a nano-vaccine candidate [Volume 4, Number 1] |
|
Hekmat , S
Preparation and characterization of PLGA Nanoparticles containing recombinant core-NS3 Fusion protein of hepatitis C virus as a nano-vaccine candidate [Volume 4, Number 1] |
|
Yaghoubi , M
Cost effectiveness of influenza vaccination for specific populations in Iran [Volume 4, Number 1] |
|
Zahraei , SM
Cost effectiveness of influenza vaccination for specific populations in Iran [Volume 4, Number 1] |
|
Amiri , J
Cost effectiveness of influenza vaccination for specific populations in Iran [Volume 4, Number 1] |
|
Kheiltash , A
Cost effectiveness of influenza vaccination for specific populations in Iran [Volume 4, Number 1] |
|
Moradi-Lakeh , M
Cost effectiveness of influenza vaccination for specific populations in Iran [Volume 4, Number 1] |
|
Sanaei , Z
Cost effectiveness of influenza vaccination for specific populations in Iran [Volume 4, Number 1] |
|
Tafreshi , SH
BCG vaccine and pulmonary tuberculosis [Volume 4, Number 1] |
|
Bouzari , S
Bioinformatics analysis and expression of a truncated form of Proteus mirabilis Pta protein as a novel vaccine target against urinary tract infection [Volume 3, Number 3] |
|
Ghasemi , A
Bioinformatics analysis and expression of a truncated form of Proteus mirabilis Pta protein as a novel vaccine target against urinary tract infection [Volume 3, Number 3] |
|
Habibi , M
Bioinformatics analysis and expression of a truncated form of Proteus mirabilis Pta protein as a novel vaccine target against urinary tract infection [Volume 3, Number 3] |
|
Khorshidi, A
Bioinformatics analysis and expression of a truncated form of Proteus mirabilis Pta protein as a novel vaccine target against urinary tract infection [Volume 3, Number 3] |
|
Asadi Karam, MR
Bioinformatics analysis and expression of a truncated form of Proteus mirabilis Pta protein as a novel vaccine target against urinary tract infection [Volume 3, Number 3] |
|
Choubini , E
Bioinformatics analysis and expression of a truncated form of Proteus mirabilis Pta protein as a novel vaccine target against urinary tract infection [Volume 3, Number 3] |
|
Jodairi Eslami , S
Evaluation of the effects of concentration, duration and temperature of incubation with Beta-Propiolactone on inactivation of cell-derived rabies virus [Volume 3, Number 3] |
|
Hosseini , SM
Evaluation of the effects of concentration, duration and temperature of incubation with Beta-Propiolactone on inactivation of cell-derived rabies virus [Volume 3, Number 3] |
|
Vaez, J
Evaluation of the effects of concentration, duration and temperature of incubation with Beta-Propiolactone on inactivation of cell-derived rabies virus [Volume 3, Number 3] |
|
Mehrbod, P
Evaluation of the effects of concentration, duration and temperature of incubation with Beta-Propiolactone on inactivation of cell-derived rabies virus [Volume 3, Number 3] |
|
Eftekhari, Z
Evaluation of the effects of concentration, duration and temperature of incubation with Beta-Propiolactone on inactivation of cell-derived rabies virus [Volume 3, Number 3] |
|
Siadat, SD
Cloning and expression of porA gene as the first step of a vaccine candidate study against Neisseria meningitidis serogroup A infection [Volume 3, Number 3] |
|
Vaziri, F
Cloning and expression of porA gene as the first step of a vaccine candidate study against Neisseria meningitidis serogroup A infection [Volume 3, Number 3] |
|
Fateh, A
Cloning and expression of porA gene as the first step of a vaccine candidate study against Neisseria meningitidis serogroup A infection [Volume 3, Number 3] |
|
Malekan, MA
Cloning and expression of porA gene as the first step of a vaccine candidate study against Neisseria meningitidis serogroup A infection [Volume 3, Number 3] |
|
Davari, M
Cloning and expression of porA gene as the first step of a vaccine candidate study against Neisseria meningitidis serogroup A infection [Volume 3, Number 3] |
|
Behrouzi , A
Cloning and expression of porA gene as the first step of a vaccine candidate study against Neisseria meningitidis serogroup A infection [Volume 3, Number 3] |
|
Afrough , P
Cloning and expression of porA gene as the first step of a vaccine candidate study against Neisseria meningitidis serogroup A infection [Volume 3, Number 3] |
|
Hadadian , Shahin
Purification of human anti-erythropoietin polyclonal antibodies by precipitation and chromatography as an optimized method with potential application in vaccine studies [Volume 3, Number 3] |
|
Yaghoubi , Hashem
Purification of human anti-erythropoietin polyclonal antibodies by precipitation and chromatography as an optimized method with potential application in vaccine studies [Volume 3, Number 3] |
|
Maboudi , Kourosh
Purification of human anti-erythropoietin polyclonal antibodies by precipitation and chromatography as an optimized method with potential application in vaccine studies [Volume 3, Number 3] |
|
Farahmand , B
Construction of chimeric protein 3M2e.FliC and its immunoinformatics analyses and expression in Bacillus subtilis [Volume 3, Number 3] |
|
Behzadian , F
Construction of chimeric protein 3M2e.FliC and its immunoinformatics analyses and expression in Bacillus subtilis [Volume 3, Number 3] |
|
Moeini , S
Construction of chimeric protein 3M2e.FliC and its immunoinformatics analyses and expression in Bacillus subtilis [Volume 3, Number 3] |
|
Shahsavandi , S
Comparison of two gel filtration chromatography resins for the purification of foot-and-mouth disease virus as a purified vaccine antigen [Volume 3, Number 3] |
|
Azimi , M
Comparison of two gel filtration chromatography resins for the purification of foot-and-mouth disease virus as a purified vaccine antigen [Volume 3, Number 3] |
|
Mahravani , H
Comparison of two gel filtration chromatography resins for the purification of foot-and-mouth disease virus as a purified vaccine antigen [Volume 3, Number 3] |
|
Hosseini , P
Comparison of two gel filtration chromatography resins for the purification of foot-and-mouth disease virus as a purified vaccine antigen [Volume 3, Number 3] |
|
Aghasadeghi , MR
The Shift of HAV Infection in to adulthood in Iran: Consideration for HAV Vaccination [Volume 3, Number 1] |
|
Pourbakhsh , A
Bioinformatics study of complete amino acid sequences of neuraminidase (NA) antigen of H1N1 influenza viruses from 2006 to 2013 in Iran [Volume 3, Number 1] |
|
Bayatzadeh , MA
Bioinformatics study of complete amino acid sequences of neuraminidase (NA) antigen of H1N1 influenza viruses from 2006 to 2013 in Iran [Volume 3, Number 1] |
|
Ashtari , A
Bioinformatics study of complete amino acid sequences of neuraminidase (NA) antigen of H1N1 influenza viruses from 2006 to 2013 in Iran [Volume 3, Number 1] |
|
Kavousi , K
Bioinformatics study of complete amino acid sequences of neuraminidase (NA) antigen of H1N1 influenza viruses from 2006 to 2013 in Iran [Volume 3, Number 1] |
|
Goliaei , B
Bioinformatics study of complete amino acid sequences of neuraminidase (NA) antigen of H1N1 influenza viruses from 2006 to 2013 in Iran [Volume 3, Number 1] |
|
Farhangi , A
Bioinformatics study of complete amino acid sequences of neuraminidase (NA) antigen of H1N1 influenza viruses from 2006 to 2013 in Iran [Volume 3, Number 1] |
|
Bahrmand , A
Differential protein expression in Mycobacterium tuberculosis susceptible and multidrug resistant isolates [Volume 3, Number 1] |
|
Niknami , S
Differential protein expression in Mycobacterium tuberculosis susceptible and multidrug resistant isolates [Volume 3, Number 1] |
|
Siadat , SD
Differential protein expression in Mycobacterium tuberculosis susceptible and multidrug resistant isolates [Volume 3, Number 1] |
|
Ghanei , M
Differential protein expression in Mycobacterium tuberculosis susceptible and multidrug resistant isolates [Volume 3, Number 1] |
|
Yari , Sh
Differential protein expression in Mycobacterium tuberculosis susceptible and multidrug resistant isolates [Volume 3, Number 1] |
|
Hadizadeh Tasbiti , AR
Differential protein expression in Mycobacterium tuberculosis susceptible and multidrug resistant isolates [Volume 3, Number 1] |
|
Shahrooei , M
Purification and evaluation of glycerol teichoic acid from biofilm forming Staphylococcus epidermidis as a putative vaccine candidate [Volume 3, Number 1] |
|
Farjah , A
Purification and evaluation of glycerol teichoic acid from biofilm forming Staphylococcus epidermidis as a putative vaccine candidate [Volume 3, Number 1] |
|
Siadat , SD
Purification and evaluation of glycerol teichoic acid from biofilm forming Staphylococcus epidermidis as a putative vaccine candidate [Volume 3, Number 1] |
|
Babaei , R
Purification and evaluation of glycerol teichoic acid from biofilm forming Staphylococcus epidermidis as a putative vaccine candidate [Volume 3, Number 1] |
|
Moosavi , SF
Purification and evaluation of glycerol teichoic acid from biofilm forming Staphylococcus epidermidis as a putative vaccine candidate [Volume 3, Number 1] |
|
Mirzaei , B
Purification and evaluation of glycerol teichoic acid from biofilm forming Staphylococcus epidermidis as a putative vaccine candidate [Volume 3, Number 1] |
|
Heidarieh, M
Immunization of Litopenaeus vannamei shrimp against white spot syndrome virus (WSSV) by gamma-irradiated WSSV plus Vibrio paraheomolyticus [Volume 3, Number 1] |
|
Afsharnasab, M
Immunization of Litopenaeus vannamei shrimp against white spot syndrome virus (WSSV) by gamma-irradiated WSSV plus Vibrio paraheomolyticus [Volume 3, Number 1] |
|
Motamedi-Sedeh, F
Immunization of Litopenaeus vannamei shrimp against white spot syndrome virus (WSSV) by gamma-irradiated WSSV plus Vibrio paraheomolyticus [Volume 3, Number 1] |
|
Yazdani, SH
Establishment of NS3 tumor cell line expressing Hepatitis C virus Non-structural Protein 3 as valuable tool for HCV challenging in mice [Volume 3, Number 1] |
|
Aghasadeghi , MR
Establishment of NS3 tumor cell line expressing Hepatitis C virus Non-structural Protein 3 as valuable tool for HCV challenging in mice [Volume 3, Number 1] |
|
Sabahi , F
Establishment of NS3 tumor cell line expressing Hepatitis C virus Non-structural Protein 3 as valuable tool for HCV challenging in mice [Volume 3, Number 1] |
|
Sadat , SM
Establishment of NS3 tumor cell line expressing Hepatitis C virus Non-structural Protein 3 as valuable tool for HCV challenging in mice [Volume 3, Number 1] |
|
Bamdad , T
Establishment of NS3 tumor cell line expressing Hepatitis C virus Non-structural Protein 3 as valuable tool for HCV challenging in mice [Volume 3, Number 1] |
|
Pouriayevali , MH
Establishment of NS3 tumor cell line expressing Hepatitis C virus Non-structural Protein 3 as valuable tool for HCV challenging in mice [Volume 3, Number 1] |
|
Sadat , SM
Synthesis and characterization of physicochemical and immunological properties of recombinant NS3-G2 dendrimer conjugate [Volume 3, Number 1] |
|
Aghasadeghi, MR
Synthesis and characterization of physicochemical and immunological properties of recombinant NS3-G2 dendrimer conjugate [Volume 3, Number 1] |
|
Bolhassani , A
Synthesis and characterization of physicochemical and immunological properties of recombinant NS3-G2 dendrimer conjugate [Volume 3, Number 1] |
|
Shafiee Ardestani, M
Synthesis and characterization of physicochemical and immunological properties of recombinant NS3-G2 dendrimer conjugate [Volume 3, Number 1] |
|
Modaressi , MH
Synthesis and characterization of physicochemical and immunological properties of recombinant NS3-G2 dendrimer conjugate [Volume 3, Number 1] |
|
Rahimi , P
Synthesis and characterization of physicochemical and immunological properties of recombinant NS3-G2 dendrimer conjugate [Volume 3, Number 1] |
|
Javadi , F
Synthesis and characterization of physicochemical and immunological properties of recombinant NS3-G2 dendrimer conjugate [Volume 3, Number 1] |
|
Siadat , SD
New insight into the application of outer membrane vesicles of Gram-negative bacteria [Volume 3, Number 1] |
|
Arsang , A
New insight into the application of outer membrane vesicles of Gram-negative bacteria [Volume 3, Number 1] |
|
Davari , M
New insight into the application of outer membrane vesicles of Gram-negative bacteria [Volume 3, Number 1] |
|
Ghazanfari , M
New insight into the application of outer membrane vesicles of Gram-negative bacteria [Volume 3, Number 1] |
|
Ahmadi Badi , S
New insight into the application of outer membrane vesicles of Gram-negative bacteria [Volume 3, Number 1] |
|
Rahimi Janani, F
New insight into the application of outer membrane vesicles of Gram-negative bacteria [Volume 3, Number 1] |
|
Vaziri , F
New insight into the application of outer membrane vesicles of Gram-negative bacteria [Volume 3, Number 1] |
|
Fateh , A
New insight into the application of outer membrane vesicles of Gram-negative bacteria [Volume 3, Number 1] |
|
Hosseini- Vasoukolaei , N
Sand fly saliva: toward a vaccine against leishmaniases [Volume 2, Number 3] |
|
Bahrmand , A
Protein profiling and analysis of drug sensitive and multidrug resistant isolates of Mycobacterium tuberculosis by native polyacrylamide gel electrophoresis and mass spectrometry [Volume 2, Number 3] |
|
Niknami , Sh
Protein profiling and analysis of drug sensitive and multidrug resistant isolates of Mycobacterium tuberculosis by native polyacrylamide gel electrophoresis and mass spectrometry [Volume 2, Number 3] |
|
Vaziri , F
Protein profiling and analysis of drug sensitive and multidrug resistant isolates of Mycobacterium tuberculosis by native polyacrylamide gel electrophoresis and mass spectrometry [Volume 2, Number 3] |
|
Siadat , SD
Protein profiling and analysis of drug sensitive and multidrug resistant isolates of Mycobacterium tuberculosis by native polyacrylamide gel electrophoresis and mass spectrometry [Volume 2, Number 3] |
|
Fateh , A
Protein profiling and analysis of drug sensitive and multidrug resistant isolates of Mycobacterium tuberculosis by native polyacrylamide gel electrophoresis and mass spectrometry [Volume 2, Number 3] |
|
Mahdian , R
Protein profiling and analysis of drug sensitive and multidrug resistant isolates of Mycobacterium tuberculosis by native polyacrylamide gel electrophoresis and mass spectrometry [Volume 2, Number 3] |
|
Shokrgozar, MA
Protein profiling and analysis of drug sensitive and multidrug resistant isolates of Mycobacterium tuberculosis by native polyacrylamide gel electrophoresis and mass spectrometry [Volume 2, Number 3] |
|
Ghanei, M
Protein profiling and analysis of drug sensitive and multidrug resistant isolates of Mycobacterium tuberculosis by native polyacrylamide gel electrophoresis and mass spectrometry [Volume 2, Number 3] |
|
Hadizadeh Tasbiti , AR
Protein profiling and analysis of drug sensitive and multidrug resistant isolates of Mycobacterium tuberculosis by native polyacrylamide gel electrophoresis and mass spectrometry [Volume 2, Number 3] |
|
Yari , Sh
Protein profiling and analysis of drug sensitive and multidrug resistant isolates of Mycobacterium tuberculosis by native polyacrylamide gel electrophoresis and mass spectrometry [Volume 2, Number 3] |
|
Amiran , MR
Evaluation of full length E1 and E2 glycoproteins of HCV expressed in P. pastoris as a protein-based vaccine candidate [Volume 2, Number 3] |
|
Shayestehpour , M
Evaluation of full length E1 and E2 glycoproteins of HCV expressed in P. pastoris as a protein-based vaccine candidate [Volume 2, Number 3] |
|
Yazdani , Sh
Evaluation of full length E1 and E2 glycoproteins of HCV expressed in P. pastoris as a protein-based vaccine candidate [Volume 2, Number 3] |
|
Motevalli , F
Evaluation of full length E1 and E2 glycoproteins of HCV expressed in P. pastoris as a protein-based vaccine candidate [Volume 2, Number 3] |
|
Aghasadeghi , MR
Evaluation of full length E1 and E2 glycoproteins of HCV expressed in P. pastoris as a protein-based vaccine candidate [Volume 2, Number 3] |
|
Mahmoudizad , F
Evaluation of full length E1 and E2 glycoproteins of HCV expressed in P. pastoris as a protein-based vaccine candidate [Volume 2, Number 3] |
|
Vahabpour , R
Evaluation of full length E1 and E2 glycoproteins of HCV expressed in P. pastoris as a protein-based vaccine candidate [Volume 2, Number 3] |
|
Shokri , M
Evaluation of full length E1 and E2 glycoproteins of HCV expressed in P. pastoris as a protein-based vaccine candidate [Volume 2, Number 3] |
|
Solati , R
Evaluation of full length E1 and E2 glycoproteins of HCV expressed in P. pastoris as a protein-based vaccine candidate [Volume 2, Number 3] |
|
Rahimi , P
Evaluation of full length E1 and E2 glycoproteins of HCV expressed in P. pastoris as a protein-based vaccine candidate [Volume 2, Number 3] |
|
Farahmand, B
Comparison of Vero and MDCK cell lines transfected with human siat7e gene for conversion to suspension culture [Volume 2, Number 3] |
|
Mohammadpour, A
Comparison of Vero and MDCK cell lines transfected with human siat7e gene for conversion to suspension culture [Volume 2, Number 3] |
|
Irani Mokhtari , G
Comparison of Vero and MDCK cell lines transfected with human siat7e gene for conversion to suspension culture [Volume 2, Number 3] |
|
Fotouhi , F
Comparison of Vero and MDCK cell lines transfected with human siat7e gene for conversion to suspension culture [Volume 2, Number 3] |
|
Mehrbod , P
Comparison of Vero and MDCK cell lines transfected with human siat7e gene for conversion to suspension culture [Volume 2, Number 3] |
|
Shafaati , M
Construction of a recombinant bacmid DNA containing influenza A virus hemagglutinin gene using a site-specific transposition mechanism [Volume 2, Number 3] |
|
Yazdani , SH
Construction of a recombinant bacmid DNA containing influenza A virus hemagglutinin gene using a site-specific transposition mechanism [Volume 2, Number 3] |
|
Akhavan , E
Construction of a recombinant bacmid DNA containing influenza A virus hemagglutinin gene using a site-specific transposition mechanism [Volume 2, Number 3] |
|
Shafaati , MR
Construction of a recombinant bacmid DNA containing influenza A virus hemagglutinin gene using a site-specific transposition mechanism [Volume 2, Number 3] |
|
Arashkia , A
Construction and evaluation of human papillomavirus genotype 18 pseudovirions [Volume 2, Number 3] |
|
Azadmanesh , K
Construction and evaluation of human papillomavirus genotype 18 pseudovirions [Volume 2, Number 3] |
|
Langroudi , L
Construction and evaluation of human papillomavirus genotype 18 pseudovirions [Volume 2, Number 3] |
|
Barzegar , H
Construction and evaluation of human papillomavirus genotype 18 pseudovirions [Volume 2, Number 3] |
|
Sharifi , H
Construction and evaluation of human papillomavirus genotype 18 pseudovirions [Volume 2, Number 3] |
|
Bolhassani , A
Different protein expression systems can influence the direction of the immune responses against HCV core protein in animal model [Volume 2, Number 3] |
|
Davoudi , N
Different protein expression systems can influence the direction of the immune responses against HCV core protein in animal model [Volume 2, Number 3] |
|
Irani, Sh
Different protein expression systems can influence the direction of the immune responses against HCV core protein in animal model [Volume 2, Number 3] |
|
Mirnurollahi , SM
Different protein expression systems can influence the direction of the immune responses against HCV core protein in animal model [Volume 2, Number 3] |
|
Diba , Y
Strategies of Hepatitis B vaccine export to the Middle East and Central Asian countries [Volume 2, Number 3] |
|
Maleki , MR
Strategies of Hepatitis B vaccine export to the Middle East and Central Asian countries [Volume 2, Number 3] |
|
Doroud , D
Overview of the validation procedures for a vaccine production: from R&D level to the pre-qualification stage [Volume 2, Number 1] |
|
Kaghazian , H
Overview of the validation procedures for a vaccine production: from R&D level to the pre-qualification stage [Volume 2, Number 1] |
|
Eslami, M
Assessment of humoral immune response of a Cytomegalovirus DNA-vaccine candidate in BALB/c mice [Volume 2, Number 1] |
|
Monavari , SH
Assessment of humoral immune response of a Cytomegalovirus DNA-vaccine candidate in BALB/c mice [Volume 2, Number 1] |
|
Ataei- Pirkooh , A
Assessment of humoral immune response of a Cytomegalovirus DNA-vaccine candidate in BALB/c mice [Volume 2, Number 1] |
|
Keyvani , H
Assessment of humoral immune response of a Cytomegalovirus DNA-vaccine candidate in BALB/c mice [Volume 2, Number 1] |
|
Goudarzifar , F
Assessment of humoral immune response of a Cytomegalovirus DNA-vaccine candidate in BALB/c mice [Volume 2, Number 1] |
|
Aghasadeghi , MR
Assessment of humoral immune response of a Cytomegalovirus DNA-vaccine candidate in BALB/c mice [Volume 2, Number 1] |
|
Vahabpour , R
Assessment of humoral immune response of a Cytomegalovirus DNA-vaccine candidate in BALB/c mice [Volume 2, Number 1] |
|
Hadadian , Sh
Shelf-life estimation of recombinant hepatitis B vaccine using R software in comparison with WHO manual protocol [Volume 2, Number 1] |
|
Maboudi , K
Shelf-life estimation of recombinant hepatitis B vaccine using R software in comparison with WHO manual protocol [Volume 2, Number 1] |
|
Hoseini , SN
Shelf-life estimation of recombinant hepatitis B vaccine using R software in comparison with WHO manual protocol [Volume 2, Number 1] |
|
Doroud , d
Shelf-life estimation of recombinant hepatitis B vaccine using R software in comparison with WHO manual protocol [Volume 2, Number 1] |
|
Momen , SB
Shelf-life estimation of recombinant hepatitis B vaccine using R software in comparison with WHO manual protocol [Volume 2, Number 1] |
|
Hosseini , SM
Shelf-life estimation of recombinant hepatitis B vaccine using R software in comparison with WHO manual protocol [Volume 2, Number 1] |
|
Bahramali , G
Construction of pIRES2 vector encoding truncated NS3 of HCV and IL-18 for DNA vaccine studies [Volume 2, Number 1] |
|
Pouriayevali , MH
Construction of pIRES2 vector encoding truncated NS3 of HCV and IL-18 for DNA vaccine studies [Volume 2, Number 1] |
|
Motevali , F
Construction of pIRES2 vector encoding truncated NS3 of HCV and IL-18 for DNA vaccine studies [Volume 2, Number 1] |
|
Moshiri , A
Construction of pIRES2 vector encoding truncated NS3 of HCV and IL-18 for DNA vaccine studies [Volume 2, Number 1] |
|
Zavvar , M
Construction of pIRES2 vector encoding truncated NS3 of HCV and IL-18 for DNA vaccine studies [Volume 2, Number 1] |
|
Shahcheraghi, F
Allelic variations between vaccine strains and circulating strains in pxtP of Bordetella pertussis in Iran [Volume 2, Number 1] |
|
Nikbin, VS
Allelic variations between vaccine strains and circulating strains in pxtP of Bordetella pertussis in Iran [Volume 2, Number 1] |
|
Sadeghpour Heravi, F
Allelic variations between vaccine strains and circulating strains in pxtP of Bordetella pertussis in Iran [Volume 2, Number 1] |
|
Shahcheraghi, F
Molecular analysis of AbOmpA type-1 as immunogenic target for therapeutic interventions against MDR Acinetobacter baumannii infection [Volume 2, Number 1] |
|
Nemati, H
Molecular analysis of AbOmpA type-1 as immunogenic target for therapeutic interventions against MDR Acinetobacter baumannii infection [Volume 2, Number 1] |
|
Nasiri, O
Molecular analysis of AbOmpA type-1 as immunogenic target for therapeutic interventions against MDR Acinetobacter baumannii infection [Volume 2, Number 1] |
|
Bouzari, S
Molecular analysis of AbOmpA type-1 as immunogenic target for therapeutic interventions against MDR Acinetobacter baumannii infection [Volume 2, Number 1] |
|
Siadat, SD
Molecular analysis of AbOmpA type-1 as immunogenic target for therapeutic interventions against MDR Acinetobacter baumannii infection [Volume 2, Number 1] |
|
Badmasti, F
Molecular analysis of AbOmpA type-1 as immunogenic target for therapeutic interventions against MDR Acinetobacter baumannii infection [Volume 2, Number 1] |
|
Guiso, N
Impact of vaccination on epidemiology of diphtheria and pertussis [Volume 2, Number 1] |
|
Saderi, H
Highlights of the final draft of the national policy document for science, technology and innovation in vaccine production in Iran [Volume 2, Number 1] |
|
Esmailzadeh, H
Highlights of the final draft of the national policy document for science, technology and innovation in vaccine production in Iran [Volume 2, Number 1] |
|
Malekifar, S
Highlights of the final draft of the national policy document for science, technology and innovation in vaccine production in Iran [Volume 2, Number 1] |
|
Siadat, SD
Highlights of the final draft of the national policy document for science, technology and innovation in vaccine production in Iran [Volume 2, Number 1] |
|
Mirafzali, SM
Highlights of the final draft of the national policy document for science, technology and innovation in vaccine production in Iran [Volume 2, Number 1] |
|
Ghanei, M
Highlights of the final draft of the national policy document for science, technology and innovation in vaccine production in Iran [Volume 2, Number 1] |
|
Owlia, P
Highlights of the final draft of the national policy document for science, technology and innovation in vaccine production in Iran [Volume 2, Number 1] |
|
Rafati, Sima
Expressional Comparison Between Episomal and Stable Transfection of a Selected tri-fusion Protein in Leishmania tarentolae [Volume 1, Number 1] |
|
Taslimi, Yasaman
Expressional Comparison Between Episomal and Stable Transfection of a Selected tri-fusion Protein in Leishmania tarentolae [Volume 1, Number 1] |
|
Seyed, Negar
Expressional Comparison Between Episomal and Stable Transfection of a Selected tri-fusion Protein in Leishmania tarentolae [Volume 1, Number 1] |
|
Saatchi, Faeze
Expressional Comparison Between Episomal and Stable Transfection of a Selected tri-fusion Protein in Leishmania tarentolae [Volume 1, Number 1] |
|
Gholami, Elham
Expressional Comparison Between Episomal and Stable Transfection of a Selected tri-fusion Protein in Leishmania tarentolae [Volume 1, Number 1] |
|
Taheri, Tahereh
Expressional Comparison Between Episomal and Stable Transfection of a Selected tri-fusion Protein in Leishmania tarentolae [Volume 1, Number 1] |
|
Saifi, Mahnaz
Evaluation of Human Serological Response to Recombinant TB10.4 Antigen of Mycobacterium tuberculosis [Volume 1, Number 2] |
|
Jabbarzadeh, Ismail
Evaluation of Human Serological Response to Recombinant TB10.4 Antigen of Mycobacterium tuberculosis [Volume 1, Number 2] |
|
Khalili, Ghader
Evaluation of Human Serological Response to Recombinant TB10.4 Antigen of Mycobacterium tuberculosis [Volume 1, Number 2] |
|
Kimiavi Moghadam, Razieh
Evaluation of Human Serological Response to Recombinant TB10.4 Antigen of Mycobacterium tuberculosis [Volume 1, Number 2] |
|
Hoseini, Seyed Nezameddin
Safety and Immunogenicity of Hepatitis B Vaccine: a Study on Iranian Navy Personnel [Volume 1, Number 2] |
|
Haghparvar, Mohammad Hosein
Safety and Immunogenicity of Hepatitis B Vaccine: a Study on Iranian Navy Personnel [Volume 1, Number 2] |
|
Doroud, Delaram
Safety and Immunogenicity of Hepatitis B Vaccine: a Study on Iranian Navy Personnel [Volume 1, Number 2] |
|
Mahdiani, Hanie
Safety and Immunogenicity of Hepatitis B Vaccine: a Study on Iranian Navy Personnel [Volume 1, Number 2] |
|
Ghaemi, Amir
Enhanced Immune Responses of a Hepatitis C Virus core DNA Vaccine by co-Inoculating Interleukin-12 Expressing Vector in Mice [Volume 1, Number 2] |
|
Kelishdi, Mishar
Enhanced Immune Responses of a Hepatitis C Virus core DNA Vaccine by co-Inoculating Interleukin-12 Expressing Vector in Mice [Volume 1, Number 2] |
|
Tabarraie, Alijan
Enhanced Immune Responses of a Hepatitis C Virus core DNA Vaccine by co-Inoculating Interleukin-12 Expressing Vector in Mice [Volume 1, Number 2] |
|
Naderi, Malihe
Enhanced Immune Responses of a Hepatitis C Virus core DNA Vaccine by co-Inoculating Interleukin-12 Expressing Vector in Mice [Volume 1, Number 2] |
|
Saeedi, Atefeh
Enhanced Immune Responses of a Hepatitis C Virus core DNA Vaccine by co-Inoculating Interleukin-12 Expressing Vector in Mice [Volume 1, Number 2] |
|
Vahabpour, Rohollah
Design, Synthesis, Physicochemical and Immunological Characterization of Dendrimer-HBsAg Conjugate [Volume 1, Number 2] |
|
Heydari, Hossien
Design, Synthesis, Physicochemical and Immunological Characterization of Dendrimer-HBsAg Conjugate [Volume 1, Number 2] |
|
Atyabi, Seyed Mohammad
Design, Synthesis, Physicochemical and Immunological Characterization of Dendrimer-HBsAg Conjugate [Volume 1, Number 2] |
|
Momen, Seyed Bahman
Design, Synthesis, Physicochemical and Immunological Characterization of Dendrimer-HBsAg Conjugate [Volume 1, Number 2] |
|
Amini, Safieh
Design, Synthesis, Physicochemical and Immunological Characterization of Dendrimer-HBsAg Conjugate [Volume 1, Number 2] |
|
Doroud, Delaram
Design, Synthesis, Physicochemical and Immunological Characterization of Dendrimer-HBsAg Conjugate [Volume 1, Number 2] |
|
Ahangari Cohan, Reza
Design, Synthesis, Physicochemical and Immunological Characterization of Dendrimer-HBsAg Conjugate [Volume 1, Number 2] |
|
Shafiee Ardestani, Mehdi
Design, Synthesis, Physicochemical and Immunological Characterization of Dendrimer-HBsAg Conjugate [Volume 1, Number 2] |
|
Khosravy, Mohammad Sadeq
Design, Synthesis, Physicochemical and Immunological Characterization of Dendrimer-HBsAg Conjugate [Volume 1, Number 2] |
|
Hadjati, Jamshid
Effective Dendritic Cell-based Immunotherapeutic Vaccines for Acute Myeloid Leukemia (AML) [Volume 1, Number 2] |
|
Nourizadeh, Maryam
Effective Dendritic Cell-based Immunotherapeutic Vaccines for Acute Myeloid Leukemia (AML) [Volume 1, Number 2] |
|
Aghakhani, Arezoo
Immune Response to Standard Hepatitis B Vaccination in HIV-Infected Patients [Volume 1, Number 2] |
|
Eslamifar, Ali
Immune Response to Standard Hepatitis B Vaccination in HIV-Infected Patients [Volume 1, Number 2] |
|
Foroughi, Maryam
Immune Response to Standard Hepatitis B Vaccination in HIV-Infected Patients [Volume 1, Number 2] |
|
Banifazl, Mohammad
Immune Response to Standard Hepatitis B Vaccination in HIV-Infected Patients [Volume 1, Number 2] |
|
Mohraz, Minoo
Immune Response to Standard Hepatitis B Vaccination in HIV-Infected Patients [Volume 1, Number 2] |
|
Ramezani, Amitis
Immune Response to Standard Hepatitis B Vaccination in HIV-Infected Patients [Volume 1, Number 2] |
|
Sardari, Soroush
Design and in Silico Construction of New Efficient Antibodies Against Gastric Tumor-associated Antigens Towards Introducing Combined Strategy for Vaccine Tumor Therapy [Volume 1, Number 2] |
|
Maslehat, Sholeh
Design and in Silico Construction of New Efficient Antibodies Against Gastric Tumor-associated Antigens Towards Introducing Combined Strategy for Vaccine Tumor Therapy [Volume 1, Number 2] |
|
Mazinani, Zohreh
Design and in Silico Construction of New Efficient Antibodies Against Gastric Tumor-associated Antigens Towards Introducing Combined Strategy for Vaccine Tumor Therapy [Volume 1, Number 2] |
|
Shahidi, Sakineh
Design and in Silico Construction of New Efficient Antibodies Against Gastric Tumor-associated Antigens Towards Introducing Combined Strategy for Vaccine Tumor Therapy [Volume 1, Number 2] |
|
Ghavami, Ghazaleh
Design and in Silico Construction of New Efficient Antibodies Against Gastric Tumor-associated Antigens Towards Introducing Combined Strategy for Vaccine Tumor Therapy [Volume 1, Number 2] |
|
D. Djadid, Navid
Optimized Method for Purification of Expressed Plasmodium Vivax Duffy Binding Protein-II (PvDBP-II): Implication for Vivax Malaria Vaccine Development [Volume 1, Number 2] |
|
Zakeri, Sedigheh
Optimized Method for Purification of Expressed Plasmodium Vivax Duffy Binding Protein-II (PvDBP-II): Implication for Vivax Malaria Vaccine Development [Volume 1, Number 2] |
|
Vaziri, Behrouz
Optimized Method for Purification of Expressed Plasmodium Vivax Duffy Binding Protein-II (PvDBP-II): Implication for Vivax Malaria Vaccine Development [Volume 1, Number 2] |
|
Mirkazemi, Sedigheh
Optimized Method for Purification of Expressed Plasmodium Vivax Duffy Binding Protein-II (PvDBP-II): Implication for Vivax Malaria Vaccine Development [Volume 1, Number 2] |
|
Valizadeh, Vahideh
Optimized Method for Purification of Expressed Plasmodium Vivax Duffy Binding Protein-II (PvDBP-II): Implication for Vivax Malaria Vaccine Development [Volume 1, Number 2] |
|
Tavassoti Kheiri, Masoumeh
Optimization of Microcarrier-based MDCK-SIAT1 Culture System for Influenza Virus Propagation [Volume 1, Number 1] |
|
Biglari, Peyvand
Optimization of Microcarrier-based MDCK-SIAT1 Culture System for Influenza Virus Propagation [Volume 1, Number 1] |
|
Namvar Asl, Nabiollah
Optimization of Microcarrier-based MDCK-SIAT1 Culture System for Influenza Virus Propagation [Volume 1, Number 1] |
|
Amini Rissehei, Abdolhossein
Optimization of Microcarrier-based MDCK-SIAT1 Culture System for Influenza Virus Propagation [Volume 1, Number 1] |
|
Gholami, Shima
Optimization of Microcarrier-based MDCK-SIAT1 Culture System for Influenza Virus Propagation [Volume 1, Number 1] |
|
Jamali, Abbas
Optimization of Microcarrier-based MDCK-SIAT1 Culture System for Influenza Virus Propagation [Volume 1, Number 1] |
|
Soleimanjahi, Hoorieh
Optimization of Microcarrier-based MDCK-SIAT1 Culture System for Influenza Virus Propagation [Volume 1, Number 1] |
|
Abdoli, Asghar
Optimization of Microcarrier-based MDCK-SIAT1 Culture System for Influenza Virus Propagation [Volume 1, Number 1] |
|
Ahangari Cohan, Reza
Evaluation of the Effect of Silver Nanoparticles on Induction of Neutraliz-ing Antibodies against Inactivated Rabies Virus [Volume 1, Number 1] |
|
Shoari, Alireza
Evaluation of the Effect of Silver Nanoparticles on Induction of Neutraliz-ing Antibodies against Inactivated Rabies Virus [Volume 1, Number 1] |
|
Ahangari Cohan, Hossein
Evaluation of the Effect of Silver Nanoparticles on Induction of Neutraliz-ing Antibodies against Inactivated Rabies Virus [Volume 1, Number 1] |
|
Poortaghi, Hadi
Evaluation of the Effect of Silver Nanoparticles on Induction of Neutraliz-ing Antibodies against Inactivated Rabies Virus [Volume 1, Number 1] |
|
Bashar, Rouzbeh
Evaluation of the Effect of Silver Nanoparticles on Induction of Neutraliz-ing Antibodies against Inactivated Rabies Virus [Volume 1, Number 1] |
|
Namvar Asl, Nabiollah
Evaluation of the Effect of Silver Nanoparticles on Induction of Neutraliz-ing Antibodies against Inactivated Rabies Virus [Volume 1, Number 1] |
|
Janani, Alireza
Evaluation of the Effect of Silver Nanoparticles on Induction of Neutraliz-ing Antibodies against Inactivated Rabies Virus [Volume 1, Number 1] |
|
Khosravy, Mohammad Sadeq
Evaluation of the Effect of Silver Nanoparticles on Induction of Neutraliz-ing Antibodies against Inactivated Rabies Virus [Volume 1, Number 1] |
|
Kord Mafi, Omid
Evaluation of the Effect of Silver Nanoparticles on Induction of Neutraliz-ing Antibodies against Inactivated Rabies Virus [Volume 1, Number 1] |
|
Asgary, Vahid
Evaluation of the Effect of Silver Nanoparticles on Induction of Neutraliz-ing Antibodies against Inactivated Rabies Virus [Volume 1, Number 1] |
|
Siadat, Seyed Davar
Extraction and Purification of Haemophilus influenzae Type b Lipooligosaccharide by Modified Phenol Method [Volume 1, Number 1] |
|
Bahremand, Ahmad Reza
Extraction and Purification of Haemophilus influenzae Type b Lipooligosaccharide by Modified Phenol Method [Volume 1, Number 1] |
|
Nejati, Mehdi
Extraction and Purification of Haemophilus influenzae Type b Lipooligosaccharide by Modified Phenol Method [Volume 1, Number 1] |
|
Vaziri, Farzam
Extraction and Purification of Haemophilus influenzae Type b Lipooligosaccharide by Modified Phenol Method [Volume 1, Number 1] |
|
Nour Neamatollahi, Ali
Extraction and Purification of Haemophilus influenzae Type b Lipooligosaccharide by Modified Phenol Method [Volume 1, Number 1] |
|
Masoumi, Morteza
Extraction and Purification of Haemophilus influenzae Type b Lipooligosaccharide by Modified Phenol Method [Volume 1, Number 1] |
|
Yari, Shamsi
Extraction and Purification of Haemophilus influenzae Type b Lipooligosaccharide by Modified Phenol Method [Volume 1, Number 1] |
|
Arsang, Amin
Extraction and Purification of Haemophilus influenzae Type b Lipooligosaccharide by Modified Phenol Method [Volume 1, Number 1] |
|
Vahabpour, Rouhollah
Efficacy of Purified Vero Cell Rabies Vaccine (PVRV) under the Zagreb Regimen in Iran [Volume 1, Number 1] |
|
Shamsipour, Mansour
Efficacy of Purified Vero Cell Rabies Vaccine (PVRV) under the Zagreb Regimen in Iran [Volume 1, Number 1] |
|
Howaizi, Nader
Efficacy of Purified Vero Cell Rabies Vaccine (PVRV) under the Zagreb Regimen in Iran [Volume 1, Number 1] |
|
Sharifian, Jamal
Efficacy of Purified Vero Cell Rabies Vaccine (PVRV) under the Zagreb Regimen in Iran [Volume 1, Number 1] |
|
Fallahian, Vida
Efficacy of Purified Vero Cell Rabies Vaccine (PVRV) under the Zagreb Regimen in Iran [Volume 1, Number 1] |
|
Farahtaj, Firouzeh
Efficacy of Purified Vero Cell Rabies Vaccine (PVRV) under the Zagreb Regimen in Iran [Volume 1, Number 1] |
|
Shirzadi, Mohammad Reza
Efficacy of Purified Vero Cell Rabies Vaccine (PVRV) under the Zagreb Regimen in Iran [Volume 1, Number 1] |
|
Rahimi, Pooneh
Efficacy of Purified Vero Cell Rabies Vaccine (PVRV) under the Zagreb Regimen in Iran [Volume 1, Number 1] |
|
Agi, Elnaz
DNA-Based Vaccine Is More Efficient than Non-Pathogenic Live Vaccine for the Prevention of HPV16 E7-Overexpressing Cancers [Volume 1, Number 1] |
|
Bolhassani, Azam
DNA-Based Vaccine Is More Efficient than Non-Pathogenic Live Vaccine for the Prevention of HPV16 E7-Overexpressing Cancers [Volume 1, Number 1] |
|
Hosseinzadeh, Sahar
DNA-Based Vaccine Is More Efficient than Non-Pathogenic Live Vaccine for the Prevention of HPV16 E7-Overexpressing Cancers [Volume 1, Number 1] |
|
Daemi, Amin
DNA-Based Vaccine Is More Efficient than Non-Pathogenic Live Vaccine for the Prevention of HPV16 E7-Overexpressing Cancers [Volume 1, Number 1] |
|
Bouzari, Saeid
In silico Design of Truncated Omp31 Protein of Brucella melitensis: Its Cloning and High Level Expression in Escherichia coli [Volume 1, Number 1] |
|
Zandi, Payam
In silico Design of Truncated Omp31 Protein of Brucella melitensis: Its Cloning and High Level Expression in Escherichia coli [Volume 1, Number 1] |
|
Golshani, Maryam
In silico Design of Truncated Omp31 Protein of Brucella melitensis: Its Cloning and High Level Expression in Escherichia coli [Volume 1, Number 1] |
|
Mahdavi, Mehdi
Cloning, Expression and Purification of a Novel Multi-epitopic HIV-1 Vaccine Candidate: A Preliminary Study on Immunoreactivity [Volume 1, Number 1] |
|
Shahosseini, Zahra
Cloning, Expression and Purification of a Novel Multi-epitopic HIV-1 Vaccine Candidate: A Preliminary Study on Immunoreactivity [Volume 1, Number 1] |
|
Taghizadeh, Morteza
Cloning, Expression and Purification of a Novel Multi-epitopic HIV-1 Vaccine Candidate: A Preliminary Study on Immunoreactivity [Volume 1, Number 1] |
|
Khoramabadi, Nima
Cloning, Expression and Purification of a Novel Multi-epitopic HIV-1 Vaccine Candidate: A Preliminary Study on Immunoreactivity [Volume 1, Number 1] |
|
Aghababa, Haniyeh
Cloning, Expression and Purification of a Novel Multi-epitopic HIV-1 Vaccine Candidate: A Preliminary Study on Immunoreactivity [Volume 1, Number 1] |
|
Kohram, Fatemeh
Cloning, Expression and Purification of a Novel Multi-epitopic HIV-1 Vaccine Candidate: A Preliminary Study on Immunoreactivity [Volume 1, Number 1] |
|
Memarnejadian, Arash
Cloning, Expression and Purification of a Novel Multi-epitopic HIV-1 Vaccine Candidate: A Preliminary Study on Immunoreactivity [Volume 1, Number 1] |
|
Aghasadeghi, Mohammad Reza
Cloning, Expression and Purification of a Novel Multi-epitopic HIV-1 Vaccine Candidate: A Preliminary Study on Immunoreactivity [Volume 1, Number 1] |
|
Arabi, Samira
Cloning, Expression and Purification of a Novel Multi-epitopic HIV-1 Vaccine Candidate: A Preliminary Study on Immunoreactivity [Volume 1, Number 1] |
